Owner |
Relationship |
Date |
Transaction |
Cost |
# Shares |
Value($) |
Total Shares |
Form 4 |
Vounatsos Michel |
Chief Executive Officer |
Feb 15, 2019 |
Option Exercise |
$332.87 |
2,340 |
778,916 |
16,574 |
Feb 20, 2019, 06:10 PM |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 15, 2019 |
Option Exercise |
$332.87 |
586 |
195,062 |
9,485 |
Feb 20, 2019, 06:08 PM |
McKenzie Paul |
EVP Pharmaceutical Oper & Tech |
Feb 15, 2019 |
Option Exercise |
$332.87 |
643 |
214,035 |
7,325 |
Feb 20, 2019, 06:07 PM |
Ehlers Michael D |
EVP, Research and Development |
Feb 15, 2019 |
Option Exercise |
$332.87 |
749 |
249,320 |
7,777 |
Feb 20, 2019, 05:54 PM |
ALEXANDER SUSAN H |
EVP Chief Legal Officer & Sec. |
Feb 15, 2019 |
Option Exercise |
$332.87 |
749 |
249,320 |
28,027 |
Feb 20, 2019, 05:53 PM |
Vounatsos Michel |
Chief Executive Officer |
Feb 12, 2019 |
Option Exercise |
$319.43 |
2,622 |
837,545 |
13,645 |
Feb 14, 2019, 06:33 PM |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 12, 2019 |
Option Exercise |
$319.43 |
2,518 |
804,325 |
8,753 |
Feb 14, 2019, 06:29 PM |
McKenzie Paul |
EVP Pharmaceutical Oper & Tech |
Feb 12, 2019 |
Option Exercise |
$319.43 |
919 |
293,556 |
6,520 |
Feb 14, 2019, 06:17 PM |
Gregory Ginger |
EVP, Human Resources |
Feb 12, 2019 |
Option Exercise |
$319.43 |
551 |
176,006 |
2,244 |
Feb 14, 2019, 06:10 PM |
Ehlers Michael D |
EVP, Research and Development |
Feb 12, 2019 |
Option Exercise |
$319.43 |
1,267 |
404,718 |
6,841 |
Feb 14, 2019, 06:07 PM |
ALEXANDER SUSAN H |
EVP Chief Legal Officer & Sec. |
Feb 12, 2019 |
Option Exercise |
$319.43 |
1,021 |
326,138 |
27,091 |
Feb 14, 2019, 06:04 PM |
DENNER ALEXANDER J |
Director |
Jan 31, 2019 |
Buy |
$330.52 |
25,800 |
8,527,393 |
517,658 |
Feb 01, 2019, 04:19 PM |
DENNER ALEXANDER J |
Director |
Jan 30, 2019 |
Buy |
$324.86 |
30,000 |
9,745,851 |
491,858 |
Feb 01, 2019, 04:19 PM |
DENNER ALEXANDER J |
Director |
Feb 01, 2019 |
Buy |
$328.45 |
7,000 |
2,299,163 |
524,658 |
Feb 01, 2019, 04:19 PM |
CAPELLO JEFFREY D |
EVP & Chief Financial Officer |
Jan 02, 2019 |
Option Exercise |
$304.69 |
414 |
126,142 |
917 |
Jan 04, 2019, 04:17 PM |
Guindo Chirfi |
EVP Glob. Mkt Acc & Cust Innov |
Dec 01, 2018 |
Option Exercise |
$333.72 |
409 |
136,491 |
2,543 |
Dec 04, 2018, 08:21 PM |
Ehlers Michael D |
EVP, Research and Development |
Sep 26, 2018 |
Sale |
$350.00 |
1,000 |
350,000 |
4,281 |
Sep 27, 2018, 04:16 PM |
Gregory Ginger |
EVP, Human Resources |
Aug 01, 2018 |
Option Exercise |
$344.06 |
163 |
56,082 |
1,044 |
Aug 03, 2018, 04:14 PM |
Ehlers Michael D |
EVP, Research and Development |
Jun 01, 2018 |
Option Exercise |
$297.09 |
1,076 |
319,669 |
5,281 |
Jun 05, 2018, 04:31 PM |
Vounatsos Michel |
Chief Executive Officer |
May 02, 2018 |
Option Exercise |
$274.13 |
750 |
205,598 |
9,368 |
May 04, 2018, 06:09 PM |
DENNER ALEXANDER J |
Director |
Apr 25, 2018 |
Buy |
$269.91 |
48,000 |
12,955,680 |
461,858 |
Apr 27, 2018, 07:48 AM |
McKenzie Paul |
EVP Pharmaceutical Oper & Tech |
Mar 01, 2018 |
Option Exercise |
$282.35 |
642 |
181,269 |
4,302 |
Mar 05, 2018, 04:41 PM |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 27, 2018 |
Sale |
$290.83 |
259 |
75,325 |
6,553 |
Feb 28, 2018, 05:39 PM |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 23, 2018 |
Option Exercise |
$292.78 |
208 |
60,898 |
6,812 |
Feb 27, 2018, 06:25 PM |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 23, 2018 |
Sale |
$293.44 |
908 |
266,444 |
6,553 |
Feb 27, 2018, 06:25 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 23, 2018 |
Option Exercise |
$292.78 |
28 |
8,198 |
4,744 |
Feb 27, 2018, 06:24 PM |
ALEXANDER SUSAN H |
EVP Chief Legal Corp Svc & Sec |
Feb 23, 2018 |
Option Exercise |
$292.78 |
381 |
111,549 |
24,844 |
Feb 27, 2018, 06:22 PM |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 22, 2018 |
Option Exercise |
$284.81 |
727 |
207,057 |
7,461 |
Feb 26, 2018, 04:12 PM |
ALEXANDER SUSAN H |
EVP Chief Legal Corp Svc & Sec |
Feb 22, 2018 |
Option Exercise |
$284.81 |
727 |
207,057 |
24,368 |
Feb 26, 2018, 12:00 AM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 22, 2018 |
Option Exercise |
$284.81 |
58 |
16,519 |
4,680 |
Feb 26, 2018, 12:00 AM |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 20, 2018 |
Sale |
$292.00 |
743 |
216,956 |
6,553 |
Feb 21, 2018, 04:10 PM |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 15, 2018 |
Sale |
$298.85 |
1,294 |
386,712 |
7,296 |
Feb 20, 2018, 08:09 PM |
Vounatsos Michel |
Chief Executive Officer |
Feb 15, 2018 |
Option Exercise |
$299.38 |
1,877 |
561,936 |
8,356 |
Feb 20, 2018, 04:27 PM |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 15, 2018 |
Option Exercise |
$299.38 |
596 |
178,430 |
8,590 |
Feb 20, 2018, 04:25 PM |
Ehlers Michael D |
EVP, Research and Development |
Feb 15, 2018 |
Option Exercise |
$299.38 |
509 |
152,384 |
4,898 |
Feb 20, 2018, 04:20 PM |
ALEXANDER SUSAN H |
EVP Chief Legal Corp Svc & Sec |
Feb 15, 2018 |
Option Exercise |
$299.38 |
510 |
152,684 |
23,460 |
Feb 20, 2018, 04:17 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 15, 2018 |
Option Exercise |
$299.38 |
56 |
16,765 |
4,544 |
Feb 20, 2018, 12:00 AM |
McKenzie Paul |
EVP Pharmaceutical Oper & Tech |
Feb 15, 2018 |
Option Exercise |
$299.38 |
442 |
132,326 |
4,412 |
Feb 20, 2018, 12:00 AM |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 12, 2018 |
Option Exercise |
$316.63 |
1,316 |
416,685 |
7,847 |
Feb 14, 2018, 06:37 PM |
PANGIA ROBERT W |
Director |
Jan 09, 2018 |
Option Exercise |
$57.83 |
5,832 |
337,265 |
23,539 |
Jan 10, 2018, 05:28 PM |
PANGIA ROBERT W |
Director |
Jan 09, 2018 |
Sale |
$329.65 |
5,832 |
1,922,519 |
17,707 |
Jan 10, 2018, 05:28 PM |
Vounatsos Michel |
Chief Executive Officer |
Dec 29, 2017 |
Buy |
$320.55 |
780 |
250,029 |
4,879 |
Jan 02, 2018, 04:21 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Dec 01, 2017 |
Option Exercise |
$319.35 |
157 |
50,138 |
4,542 |
Dec 05, 2017, 04:36 PM |
DENNER ALEXANDER J |
Director |
Nov 28, 2017 |
Buy |
$316.12 |
20,000 |
6,322,400 |
403,858 |
Nov 30, 2017, 07:30 AM |
DENNER ALEXANDER J |
Director |
Nov 29, 2017 |
Buy |
$319.84 |
10,000 |
3,198,400 |
413,858 |
Nov 30, 2017, 07:30 AM |
DENNER ALEXANDER J |
Director |
Aug 31, 2017 |
Option Exercise |
$316.56 |
933 |
295,350 |
383,858 |
Aug 31, 2017, 09:45 PM |
ALEXANDER SUSAN H |
EVP Chief Legal Corp Svc & Sec |
Jul 25, 2017 |
Sale |
$290.01 |
4,974 |
1,442,510 |
22,258 |
Jul 26, 2017, 04:22 PM |
ALEXANDER SUSAN H |
EVP Chief Legal Corp Svc & Sec |
Jul 19, 2017 |
Sale |
$285.00 |
7,758 |
2,211,030 |
27,232 |
Jul 20, 2017, 05:00 PM |
Posner Brian S |
Director |
Jun 09, 2017 |
Sale |
$256.31 |
1,084 |
277,840 |
6,330 |
Jun 12, 2017, 04:29 PM |
Ehlers Michael D |
EVP, Research and Development |
Jun 01, 2017 |
Option Exercise |
$252.38 |
747 |
188,528 |
3,616 |
Jun 05, 2017, 04:38 PM |
Vounatsos Michel |
Chief Executive Officer |
May 02, 2017 |
Option Exercise |
$271.34 |
564 |
153,036 |
4,099 |
May 04, 2017, 04:16 PM |
Vounatsos Michel |
Chief Executive Officer |
May 01, 2017 |
Buy |
$271.35 |
1,402 |
380,433 |
2,927 |
May 02, 2017, 04:18 PM |
DENNER ALEXANDER J |
Director |
Apr 27, 2017 |
Buy |
$278.50 |
73,858 |
20,569,476 |
383,858 |
May 01, 2017, 05:47 PM |
Clancy Paul J |
Executive VP and CFO |
Apr 25, 2017 |
Sale |
$290.00 |
9,892 |
2,868,680 |
10,813 |
Apr 27, 2017, 04:23 PM |
Clancy Paul J |
Executive VP and CFO |
Mar 13, 2017 |
Sale |
$291.55 |
9,891 |
2,883,721 |
20,705 |
Mar 14, 2017, 07:32 PM |
McKenzie Paul |
EVP Pharmaceutical Oper & Tech |
Mar 01, 2017 |
Option Exercise |
$293.26 |
157 |
46,042 |
561 |
Mar 03, 2017, 06:07 PM |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Mar 01, 2017 |
Sale |
$290.07 |
973 |
282,238 |
9,041 |
Mar 03, 2017, 06:02 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 28, 2017 |
Option Exercise |
$279.35 |
3,054 |
853,135 |
30,596 |
Mar 02, 2017, 05:24 PM |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 28, 2017 |
Option Exercise |
$278.17 |
2,981 |
829,217 |
10,014 |
Mar 02, 2017, 05:22 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 28, 2017 |
Option Exercise |
$278.54 |
2,409 |
670,996 |
34,990 |
Mar 02, 2017, 05:20 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 28, 2017 |
Option Exercise |
$285.23 |
89 |
25,386 |
4,505 |
Mar 02, 2017, 05:18 PM |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Feb 28, 2017 |
Option Exercise |
$286.64 |
738 |
211,542 |
8,752 |
Mar 02, 2017, 05:16 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 28, 2017 |
Option Exercise |
$278.66 |
2,456 |
684,399 |
7,177 |
Mar 02, 2017, 05:12 PM |
PANGIA ROBERT W |
Director |
Jan 09, 2017 |
Option Exercise |
$52.22 |
5,450 |
284,599 |
22,078 |
Jan 10, 2017, 04:15 PM |
PANGIA ROBERT W |
Director |
Jan 09, 2017 |
Sale |
$295.39 |
5,450 |
1,609,876 |
16,628 |
Jan 10, 2017, 04:15 PM |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Dec 01, 2016 |
Option Exercise |
$295.78 |
171 |
50,578 |
7,408 |
Dec 05, 2016, 04:34 PM |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Dec 01, 2016 |
Sale |
$296.53 |
48 |
14,233 |
7,360 |
Dec 05, 2016, 04:34 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Dec 01, 2016 |
Option Exercise |
$295.78 |
53 |
15,676 |
3,884 |
Dec 05, 2016, 04:32 PM |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Oct 04, 2016 |
Sale |
$311.94 |
262 |
81,728 |
7,579 |
Oct 05, 2016, 04:24 PM |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Oct 01, 2016 |
Option Exercise |
$313.03 |
1,888 |
591,001 |
8,221 |
Oct 04, 2016, 05:02 PM |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Oct 03, 2016 |
Sale |
$313.00 |
380 |
118,940 |
7,841 |
Oct 04, 2016, 05:02 PM |
DORSA CAROLINE |
Director |
Sep 22, 2016 |
Option Exercise |
$53.64 |
27,570 |
1,478,855 |
44,663 |
Sep 26, 2016, 04:24 PM |
DORSA CAROLINE |
Director |
Sep 22, 2016 |
Sale |
$314.00 |
27,570 |
8,656,980 |
17,093 |
Sep 26, 2016, 04:24 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 21, 2016 |
Sale |
$280.00 |
157 |
43,960 |
54,779 |
Jul 22, 2016, 05:03 PM |
Koppel Adam |
EVP, Strategy and Bus. Dev. |
Jun 06, 2016 |
Sale |
$290.00 |
555 |
160,950 |
2,402 |
Jun 07, 2016, 04:09 PM |
Koppel Adam |
EVP, Strategy and Bus. Dev. |
Jun 02, 2016 |
Option Exercise |
$289.73 |
534 |
154,716 |
2,957 |
Jun 06, 2016, 08:48 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 03, 2016 |
Sale |
$290.00 |
842 |
244,180 |
54,936 |
Jun 06, 2016, 08:14 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 01, 2016 |
Sale |
$287.97 |
487 |
140,241 |
55,778 |
Jun 02, 2016, 04:39 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
May 31, 2016 |
Sale |
$290.00 |
3,368 |
976,720 |
56,265 |
Jun 02, 2016, 04:39 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
May 25, 2016 |
Sale |
$280.00 |
157 |
43,960 |
59,633 |
May 27, 2016, 08:59 AM |
SCANGOS GEORGE A |
Chief Executive Officer |
May 02, 2016 |
Sale |
$274.74 |
487 |
133,798 |
59,790 |
May 04, 2016, 05:03 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2016 |
Option Exercise |
$274.99 |
113 |
31,074 |
3,007 |
May 02, 2016, 04:36 PM |
Koppel Adam |
EVP, Strategy and Bus. Dev. |
Apr 06, 2016 |
Sale |
$275.00 |
102 |
28,050 |
1,848 |
Apr 07, 2016, 05:03 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 06, 2016 |
Sale |
$280.00 |
157 |
43,960 |
60,277 |
Apr 07, 2016, 05:01 PM |
Artavanis-Tsakonas Spyridon |
EVP, Chief Scientific Officer |
Apr 02, 2016 |
Option Exercise |
$260.54 |
459 |
119,588 |
3,150 |
Apr 05, 2016, 05:06 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01, 2016 |
Sale |
$258.83 |
487 |
126,050 |
60,434 |
Apr 05, 2016, 05:02 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 01, 2016 |
Sale |
$261.37 |
487 |
127,287 |
60,921 |
Mar 03, 2016, 04:36 PM |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 25, 2016 |
Sale |
$261.90 |
183 |
47,928 |
7,990 |
Feb 26, 2016, 04:08 PM |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Feb 25, 2016 |
Sale |
$261.90 |
84 |
22,000 |
8,127 |
Feb 26, 2016, 04:06 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 23, 2016 |
Option Exercise |
$258.99 |
273 |
70,704 |
26,870 |
Feb 25, 2016, 05:13 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 23, 2016 |
Option Exercise |
$258.99 |
22 |
5,698 |
2,687 |
Feb 25, 2016, 05:09 PM |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Feb 23, 2016 |
Option Exercise |
$258.99 |
48 |
12,432 |
2,549 |
Feb 25, 2016, 05:07 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 23, 2016 |
Option Exercise |
$258.99 |
300 |
77,697 |
31,840 |
Feb 25, 2016, 05:05 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 23, 2016 |
Option Exercise |
$258.99 |
382 |
98,934 |
30,516 |
Feb 25, 2016, 05:04 PM |
Koppel Adam |
EVP, Strategy and Bus. Dev. |
Feb 23, 2016 |
Option Exercise |
$258.99 |
98 |
25,381 |
1,865 |
Feb 25, 2016, 05:02 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 23, 2016 |
Option Exercise |
$258.99 |
300 |
77,697 |
3,937 |
Feb 25, 2016, 05:01 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 23, 2016 |
Option Exercise |
$258.99 |
273 |
70,704 |
8,326 |
Feb 25, 2016, 04:59 PM |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Feb 23, 2016 |
Option Exercise |
$258.99 |
162 |
41,956 |
8,211 |
Feb 25, 2016, 04:57 PM |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 23, 2016 |
Option Exercise |
$258.99 |
164 |
42,474 |
8,173 |
Feb 25, 2016, 04:52 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 23, 2016 |
Option Exercise |
$258.99 |
1,395 |
361,291 |
61,417 |
Feb 25, 2016, 04:51 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 17, 2016 |
Sale |
$256.16 |
487 |
124,750 |
59,848 |
Feb 19, 2016, 04:20 PM |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 17, 2016 |
Sale |
$256.16 |
722 |
184,948 |
7,990 |
Feb 19, 2016, 04:18 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 12, 2016 |
Option Exercise |
$247.22 |
11,815 |
2,920,904 |
60,335 |
Feb 17, 2016, 06:03 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 12, 2016 |
Option Exercise |
$247.22 |
1,552 |
383,685 |
30,088 |
Feb 17, 2016, 06:01 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 12, 2016 |
Option Exercise |
$247.22 |
1,369 |
338,444 |
3,601 |
Feb 17, 2016, 06:00 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 12, 2016 |
Option Exercise |
$247.22 |
26 |
6,428 |
2,643 |
Feb 17, 2016, 05:59 PM |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 12, 2016 |
Option Exercise |
$247.22 |
1,827 |
451,671 |
8,712 |
Feb 17, 2016, 05:57 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 12, 2016 |
Option Exercise |
$247.22 |
1,314 |
324,847 |
8,020 |
Feb 17, 2016, 05:56 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 12, 2016 |
Option Exercise |
$247.22 |
1,328 |
328,308 |
31,504 |
Feb 17, 2016, 05:55 PM |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Feb 12, 2016 |
Option Exercise |
$247.22 |
352 |
87,021 |
2,452 |
Feb 17, 2016, 05:54 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 12, 2016 |
Option Exercise |
$247.22 |
1,699 |
420,027 |
26,564 |
Feb 17, 2016, 05:53 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 09, 2016 |
Option Exercise |
$249.99 |
5,305 |
1,326,197 |
47,059 |
Feb 10, 2016, 04:19 PM |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 08, 2016 |
Option Exercise |
$250.77 |
426 |
106,828 |
8,592 |
Feb 10, 2016, 04:17 PM |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 09, 2016 |
Sale |
$246.54 |
852 |
210,052 |
7,740 |
Feb 10, 2016, 04:17 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 08, 2016 |
Option Exercise |
$250.77 |
822 |
206,133 |
29,543 |
Feb 09, 2016, 04:58 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 08, 2016 |
Option Exercise |
$250.77 |
1,047 |
262,556 |
24,404 |
Feb 09, 2016, 04:53 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 08, 2016 |
Option Exercise |
$250.77 |
1,324 |
332,019 |
28,342 |
Feb 09, 2016, 04:51 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 08, 2016 |
Option Exercise |
$250.77 |
890 |
223,185 |
6,140 |
Feb 09, 2016, 04:48 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 01, 2016 |
Option Exercise |
$273.45 |
812 |
222,041 |
1,654 |
Feb 02, 2016, 04:05 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 01, 2016 |
Option Exercise |
$273.45 |
2,466 |
674,328 |
2,466 |
Feb 02, 2016, 04:05 PM |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Dec 03, 2015 |
Option Exercise |
$275.44 |
393 |
108,248 |
8,181 |
Dec 07, 2015, 04:20 PM |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Dec 04, 2015 |
Sale |
$277.00 |
441 |
122,157 |
7,740 |
Dec 07, 2015, 04:20 PM |
Karaboutis Adriana |
EVP, Tech. and Bus. Solutions |
Dec 01, 2015 |
Option Exercise |
$290.04 |
171 |
49,597 |
7,923 |
Dec 03, 2015, 04:19 PM |
Karaboutis Adriana |
EVP, Tech. and Bus. Solutions |
Dec 02, 2015 |
Sale |
$289.14 |
48 |
13,879 |
7,875 |
Dec 03, 2015, 04:19 PM |
DENNER ALEXANDER J |
Director |
Oct 23, 2015 |
Buy |
$276.77 |
100,000 |
27,676,999 |
310,000 |
Oct 26, 2015, 07:03 PM |
DENNER ALEXANDER J |
Director |
Oct 22, 2015 |
Buy |
$277.80 |
210,000 |
58,337,997 |
210,000 |
Oct 26, 2015, 07:03 PM |
Karaboutis Adriana |
EVP, Tech. and Bus. Solutions |
Oct 05, 2015 |
Sale |
$291.43 |
269 |
78,395 |
8,094 |
Oct 06, 2015, 04:40 PM |
Karaboutis Adriana |
EVP, Tech. and Bus. Solutions |
Oct 01, 2015 |
Option Exercise |
$287.30 |
1,666 |
478,642 |
9,642 |
Oct 05, 2015, 04:10 PM |
Karaboutis Adriana |
EVP, Tech. and Bus. Solutions |
Oct 02, 2015 |
Sale |
$283.38 |
417 |
118,169 |
8,363 |
Oct 05, 2015, 04:10 PM |
PAPADOPOULOS STELIOS |
Director |
Jul 27, 2015 |
Buy |
$304.78 |
5,000 |
1,523,880 |
5,000 |
Jul 27, 2015, 05:03 PM |
PAPADOPOULOS STELIOS |
Director |
Jul 27, 2015 |
Buy |
$304.98 |
5,000 |
1,524,895 |
5,000 |
Jul 27, 2015, 05:03 PM |
Posner Brian S |
Director |
Jun 22, 2015 |
Sale |
$415.00 |
470 |
195,050 |
5,275 |
Jun 23, 2015, 04:14 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Jun 19, 2015 |
Sale |
$410.00 |
3,841 |
1,574,810 |
11,817 |
Jun 22, 2015, 04:15 PM |
Posner Brian S |
Director |
Jun 15, 2015 |
Sale |
$386.64 |
400 |
154,656 |
5,745 |
Jun 16, 2015, 06:54 PM |
Koppel Adam |
SVP, Chief Strategy Officer |
Jun 02, 2015 |
Option Exercise |
$387.62 |
852 |
330,252 |
1,662 |
Jun 04, 2015, 05:49 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 01, 2015 |
Sale |
$398.87 |
1,362 |
543,261 |
41,090 |
Jun 02, 2015, 04:10 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2015 |
Option Exercise |
$386.22 |
113 |
43,643 |
1,761 |
May 05, 2015, 04:36 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2015 |
Option Exercise |
$386.22 |
347 |
134,018 |
1,874 |
May 05, 2015, 04:36 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
May 01, 2015 |
Sale |
$377.52 |
1,362 |
514,182 |
42,452 |
May 05, 2015, 04:34 PM |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Apr 02, 2015 |
Option Exercise |
$412.44 |
460 |
189,722 |
1,674 |
Apr 03, 2015, 04:24 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01, 2015 |
Sale |
$423.20 |
1,362 |
576,398 |
43,814 |
Apr 02, 2015, 04:29 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Mar 27, 2015 |
Sale |
$430.12 |
430 |
184,952 |
8,574 |
Mar 30, 2015, 04:13 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Mar 25, 2015 |
Option Exercise |
$65.85 |
5,066 |
333,571 |
37,577 |
Mar 26, 2015, 04:31 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Mar 25, 2015 |
Sale |
$449.06 |
12,010 |
5,393,211 |
25,567 |
Mar 26, 2015, 04:31 PM |
Rowinsky Eric K |
Director |
Mar 20, 2015 |
Option Exercise |
$59.82 |
11,667 |
697,920 |
22,977 |
Mar 23, 2015, 04:33 PM |
Rowinsky Eric K |
Director |
Mar 20, 2015 |
Sale |
$475.00 |
11,667 |
5,541,825 |
11,310 |
Mar 23, 2015, 04:33 PM |
Rowinsky Eric K |
Director |
Mar 19, 2015 |
Option Exercise |
$59.82 |
2,333 |
139,560 |
13,643 |
Mar 20, 2015, 05:03 PM |
Rowinsky Eric K |
Director |
Mar 19, 2015 |
Sale |
$436.14 |
2,333 |
1,017,508 |
11,310 |
Mar 20, 2015, 05:03 PM |
Rowinsky Eric K |
Director |
Mar 17, 2015 |
Option Exercise |
$59.82 |
4,667 |
279,180 |
15,977 |
Mar 18, 2015, 05:03 PM |
Rowinsky Eric K |
Director |
Mar 17, 2015 |
Sale |
$425.45 |
4,667 |
1,985,589 |
11,310 |
Mar 18, 2015, 05:03 PM |
DiPietro Kenneth |
EVP Human Resources |
Mar 16, 2015 |
Sale |
$415.46 |
803 |
333,614 |
0 |
Mar 17, 2015, 08:10 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 13, 2015 |
Sale |
$412.69 |
537 |
221,613 |
45,176 |
Mar 16, 2015, 08:39 PM |
SHERWIN STEPHEN A |
Director |
Mar 10, 2015 |
Option Exercise |
$59.82 |
6,000 |
358,920 |
10,150 |
Mar 11, 2015, 04:17 PM |
SHERWIN STEPHEN A |
Director |
Mar 10, 2015 |
Sale |
$409.67 |
6,000 |
2,458,020 |
4,150 |
Mar 11, 2015, 04:17 PM |
Rowinsky Eric K |
Director |
Mar 09, 2015 |
Option Exercise |
$59.82 |
4,666 |
279,120 |
15,976 |
Mar 11, 2015, 04:15 PM |
Rowinsky Eric K |
Director |
Mar 09, 2015 |
Sale |
$417.23 |
4,666 |
1,946,795 |
11,310 |
Mar 11, 2015, 04:15 PM |
PANGIA ROBERT W |
Director |
Mar 10, 2015 |
Option Exercise |
$47.71 |
3,625 |
172,954 |
17,998 |
Mar 11, 2015, 04:13 PM |
PANGIA ROBERT W |
Director |
Mar 10, 2015 |
Sale |
$413.40 |
3,625 |
1,498,578 |
17,798 |
Mar 11, 2015, 04:13 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Mar 01, 2015 |
Option Exercise |
$409.59 |
2,826 |
1,157,501 |
12,178 |
Mar 03, 2015, 04:44 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Mar 02, 2015 |
Sale |
$409.49 |
3,174 |
1,299,715 |
12,078 |
Mar 03, 2015, 04:44 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 02, 2015 |
Sale |
$410.67 |
825 |
338,803 |
45,713 |
Mar 03, 2015, 04:39 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 12, 2015 |
Option Exercise |
$392.11 |
8 |
3,137 |
1,302 |
Feb 23, 2015, 04:24 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 19, 2015 |
Sale |
$401.04 |
537 |
215,358 |
46,538 |
Feb 20, 2015, 04:28 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 17, 2015 |
Sale |
$389.11 |
825 |
321,016 |
47,075 |
Feb 18, 2015, 04:45 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 17, 2015 |
Sale |
$389.11 |
2,128 |
828,026 |
4,321 |
Feb 18, 2015, 04:41 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 17, 2015 |
Sale |
$389.11 |
1,188 |
462,263 |
803 |
Feb 18, 2015, 04:37 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 17, 2015 |
Sale |
$389.11 |
418 |
162,648 |
15,004 |
Feb 18, 2015, 04:36 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 12, 2015 |
Option Exercise |
$392.11 |
12,125 |
4,754,334 |
47,900 |
Feb 17, 2015, 09:32 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 12, 2015 |
Option Exercise |
$392.11 |
20 |
7,842 |
1,446 |
Feb 17, 2015, 09:16 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 12, 2015 |
Option Exercise |
$392.11 |
1,712 |
671,292 |
6,449 |
Feb 17, 2015, 08:54 PM |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Feb 12, 2015 |
Option Exercise |
$392.11 |
394 |
154,491 |
1,159 |
Feb 17, 2015, 08:50 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 12, 2015 |
Option Exercise |
$392.11 |
757 |
296,827 |
15,422 |
Feb 17, 2015, 08:47 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 12, 2015 |
Option Exercise |
$392.11 |
2,026 |
794,415 |
22,257 |
Feb 17, 2015, 08:44 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 12, 2015 |
Option Exercise |
$392.11 |
1,761 |
690,506 |
32,511 |
Feb 17, 2015, 08:40 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 12, 2015 |
Option Exercise |
$392.11 |
2,450 |
960,669 |
15,658 |
Feb 17, 2015, 08:37 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 12, 2015 |
Option Exercise |
$392.11 |
1,776 |
696,387 |
27,867 |
Feb 17, 2015, 08:34 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 12, 2015 |
Option Exercise |
$392.11 |
1,773 |
695,211 |
1,991 |
Feb 17, 2015, 08:30 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 12, 2015 |
Option Exercise |
$392.11 |
1,697 |
665,411 |
8,132 |
Feb 17, 2015, 08:26 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 10, 2015 |
Sale |
$398.11 |
1,143 |
455,039 |
15,417 |
Feb 11, 2015, 04:26 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 09, 2015 |
Option Exercise |
$396.88 |
4,940 |
1,960,587 |
24,315 |
Feb 11, 2015, 04:25 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 10, 2015 |
Option Exercise |
$395.13 |
8,871 |
3,505,198 |
34,277 |
Feb 11, 2015, 04:25 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 08, 2015 |
Option Exercise |
$402.00 |
1,634 |
656,868 |
12,908 |
Feb 10, 2015, 05:14 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 08, 2015 |
Option Exercise |
$402.00 |
818 |
328,836 |
23,807 |
Feb 10, 2015, 05:12 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 09, 2015 |
Option Exercise |
$396.88 |
1,842 |
731,053 |
25,874 |
Feb 10, 2015, 05:12 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 09, 2015 |
Option Exercise |
$396.88 |
681 |
270,275 |
15,717 |
Feb 10, 2015, 05:11 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 08, 2015 |
Option Exercise |
$402.00 |
421 |
169,242 |
15,430 |
Feb 10, 2015, 05:11 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 09, 2015 |
Sale |
$398.05 |
856 |
340,731 |
14,574 |
Feb 10, 2015, 05:11 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 08, 2015 |
Option Exercise |
$402.00 |
1,275 |
512,550 |
4,527 |
Feb 10, 2015, 05:10 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 09, 2015 |
Option Exercise |
$396.88 |
860 |
341,317 |
6,228 |
Feb 10, 2015, 05:08 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 08, 2015 |
Option Exercise |
$402.00 |
883 |
354,966 |
5,264 |
Feb 10, 2015, 05:08 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 09, 2015 |
Option Exercise |
$396.88 |
2,210 |
877,105 |
30,534 |
Feb 10, 2015, 05:07 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 08, 2015 |
Option Exercise |
$402.00 |
1,537 |
617,874 |
28,053 |
Feb 10, 2015, 05:07 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 08, 2015 |
Option Exercise |
$402.00 |
1,143 |
459,486 |
17,503 |
Feb 10, 2015, 05:06 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 09, 2015 |
Option Exercise |
$396.88 |
2,210 |
877,105 |
19,984 |
Feb 10, 2015, 05:06 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 02, 2015 |
Sale |
$389.03 |
1,656 |
644,234 |
0 |
Feb 03, 2015, 06:35 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 01, 2015 |
Option Exercise |
$389.16 |
807 |
314,052 |
1,656 |
Feb 02, 2015, 07:46 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 01, 2015 |
Option Exercise |
$389.16 |
2,059 |
801,280 |
11,074 |
Feb 02, 2015, 07:43 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 01, 2015 |
Option Exercise |
$389.16 |
2,060 |
801,670 |
3,097 |
Feb 02, 2015, 07:40 PM |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Dec 15, 2014 |
Sale |
$346.50 |
1,981 |
686,417 |
352 |
Dec 16, 2014, 04:36 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Dec 03, 2014 |
Option Exercise |
$347.34 |
393 |
136,505 |
15,014 |
Dec 05, 2014, 05:20 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Dec 04, 2014 |
Sale |
$345.88 |
440 |
152,187 |
14,574 |
Dec 05, 2014, 05:20 PM |
Holtzman Steven H |
EVP Corporate Development |
Dec 02, 2014 |
Sale |
$335.65 |
1,749 |
587,052 |
0 |
Dec 03, 2014, 04:32 PM |
Holtzman Steven H |
EVP Corporate Development |
Nov 11, 2014 |
Sale |
$330.00 |
1,750 |
577,500 |
1,749 |
Nov 12, 2014, 04:24 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Nov 03, 2014 |
Sale |
$320.78 |
1,128 |
361,840 |
17,985 |
Nov 04, 2014, 04:18 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Oct 01, 2014 |
Sale |
$330.97 |
1,127 |
373,003 |
19,113 |
Oct 02, 2014, 04:44 PM |
Holtzman Steven H |
EVP Corporate Development |
Oct 01, 2014 |
Sale |
$330.97 |
1,750 |
579,198 |
3,499 |
Oct 02, 2014, 04:42 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Sep 02, 2014 |
Sale |
$345.47 |
1,128 |
389,690 |
20,240 |
Sep 04, 2014, 04:15 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Aug 01, 2014 |
Sale |
$332.93 |
1,128 |
375,545 |
21,368 |
Aug 04, 2014, 04:43 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 16, 2014 |
Sale |
$312.37 |
12,316 |
3,847,149 |
22,496 |
Jul 18, 2014, 05:59 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 15, 2014 |
Option Exercise |
$312.00 |
10,062 |
3,139,344 |
34,812 |
Jul 17, 2014, 04:45 PM |
Posner Brian S |
Director |
Jun 20, 2014 |
Sale |
$315.00 |
605 |
190,575 |
6,000 |
Jun 23, 2014, 04:37 PM |
Posner Brian S |
Director |
Jun 13, 2014 |
Sale |
$310.50 |
700 |
217,350 |
6,605 |
Jun 16, 2014, 04:37 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 02, 2014 |
Sale |
$318.93 |
484 |
154,362 |
23,535 |
Jun 03, 2014, 04:29 PM |
Holtzman Steven H |
EVP Corporate Development |
May 19, 2014 |
Sale |
$289.15 |
1,221 |
353,052 |
5,749 |
May 20, 2014, 04:16 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
May 01, 2014 |
Sale |
$285.56 |
2,123 |
606,241 |
25,656 |
May 02, 2014, 04:22 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2014 |
Option Exercise |
$286.75 |
113 |
32,403 |
916 |
May 02, 2014, 04:20 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2014 |
Option Exercise |
$286.75 |
347 |
99,502 |
1,029 |
May 02, 2014, 04:20 PM |
Holtzman Steven H |
EVP Corporate Development |
Apr 17, 2014 |
Sale |
$291.00 |
1,221 |
355,311 |
6,970 |
Apr 21, 2014, 05:07 PM |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Apr 02, 2014 |
Option Exercise |
$309.70 |
433 |
134,100 |
2,244 |
Apr 03, 2014, 04:27 PM |
PANGIA ROBERT W |
Director |
Apr 01, 2014 |
Option Exercise |
$47.55 |
6,250 |
297,187 |
20,253 |
Apr 02, 2014, 04:19 PM |
PANGIA ROBERT W |
Director |
Apr 01, 2014 |
Sale |
$308.42 |
6,250 |
1,927,625 |
14,003 |
Apr 02, 2014, 04:19 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01, 2014 |
Sale |
$308.42 |
2,123 |
654,776 |
26,142 |
Apr 02, 2014, 04:16 PM |
Posner Brian S |
Director |
Mar 31, 2014 |
Sale |
$296.76 |
3,000 |
890,275 |
8,935 |
Apr 01, 2014, 04:15 PM |
DORSA CAROLINE |
Director |
Mar 20, 2014 |
Option Exercise |
$53.64 |
10,000 |
536,400 |
24,468 |
Mar 21, 2014, 04:17 PM |
DORSA CAROLINE |
Director |
Mar 20, 2014 |
Sale |
$348.88 |
10,000 |
3,488,812 |
22,268 |
Mar 21, 2014, 04:17 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Mar 19, 2014 |
Sale |
$352.29 |
3,505 |
1,234,776 |
9,886 |
Mar 21, 2014, 04:15 PM |
Holtzman Steven H |
EVP Corporate Development |
Mar 17, 2014 |
Sale |
$334.83 |
1,221 |
408,827 |
8,191 |
Mar 18, 2014, 05:08 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 10, 2014 |
Sale |
$333.77 |
26,124 |
8,719,378 |
53,689 |
Mar 12, 2014, 07:20 PM |
LEAMING NANCY |
Director |
Mar 10, 2014 |
Sale |
$327.65 |
2,000 |
655,300 |
7,660 |
Mar 12, 2014, 07:16 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Mar 11, 2014 |
Sale |
$336.83 |
8,428 |
2,838,766 |
9,054 |
Mar 12, 2014, 07:15 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Mar 04, 2014 |
Sale |
$342.58 |
3,171 |
1,086,321 |
15,407 |
Mar 05, 2014, 03:12 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Mar 03, 2014 |
Option Exercise |
$340.68 |
2,829 |
963,784 |
18,578 |
Mar 04, 2014, 03:22 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 03, 2014 |
Sale |
$335.79 |
2,942 |
987,894 |
56,368 |
Mar 04, 2014, 03:19 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 26, 2014 |
Sale |
$342.17 |
1,048 |
358,594 |
21,407 |
Feb 27, 2014, 04:19 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 23, 2014 |
Option Exercise |
$347.11 |
940 |
326,283 |
22,455 |
Feb 25, 2014, 02:21 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 23, 2014 |
Option Exercise |
$347.11 |
1,228 |
426,251 |
25,478 |
Feb 25, 2014, 02:17 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 23, 2014 |
Option Exercise |
$347.11 |
2,018 |
700,468 |
15,455 |
Feb 25, 2014, 02:11 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 23, 2014 |
Option Exercise |
$347.11 |
1,803 |
625,839 |
22,127 |
Feb 25, 2014, 02:07 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 18, 2014 |
Sale |
$327.90 |
1,222 |
400,694 |
9,412 |
Feb 19, 2014, 04:23 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 12, 2014 |
Option Exercise |
$323.04 |
1,685 |
544,322 |
11,481 |
Feb 14, 2014, 04:48 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 12, 2014 |
Option Exercise |
$323.04 |
1,324 |
427,705 |
13,193 |
Feb 14, 2014, 04:46 PM |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Feb 12, 2014 |
Option Exercise |
$323.04 |
239 |
77,207 |
1,702 |
Feb 14, 2014, 04:45 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 12, 2014 |
Option Exercise |
$323.04 |
1,010 |
326,270 |
20,109 |
Feb 14, 2014, 04:43 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 12, 2014 |
Option Exercise |
$323.04 |
367 |
118,556 |
14,092 |
Feb 14, 2014, 04:42 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 13, 2014 |
Sale |
$316.42 |
425 |
134,478 |
21,407 |
Feb 14, 2014, 04:42 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 12, 2014 |
Option Exercise |
$323.04 |
1,010 |
326,270 |
10,634 |
Feb 14, 2014, 04:39 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 12, 2014 |
Option Exercise |
$323.04 |
8 |
2,584 |
682 |
Feb 14, 2014, 04:38 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 12, 2014 |
Option Exercise |
$323.04 |
4,333 |
1,399,732 |
57,817 |
Feb 14, 2014, 04:37 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 13, 2014 |
Sale |
$316.81 |
486 |
153,970 |
57,331 |
Feb 14, 2014, 04:37 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 12, 2014 |
Option Exercise |
$323.04 |
956 |
308,826 |
1,290 |
Feb 14, 2014, 04:36 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 13, 2014 |
Sale |
$316.81 |
1,290 |
408,685 |
0 |
Feb 14, 2014, 04:36 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 12, 2014 |
Option Exercise |
$323.04 |
1,059 |
342,099 |
24,108 |
Feb 14, 2014, 04:34 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 11, 2014 |
Sale |
$314.31 |
2,085 |
655,336 |
14,522 |
Feb 12, 2014, 05:03 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 11, 2014 |
Sale |
$314.31 |
2,456 |
771,945 |
54,454 |
Feb 12, 2014, 05:00 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 10, 2014 |
Option Exercise |
$315.54 |
8,880 |
2,801,995 |
55,417 |
Feb 11, 2014, 07:55 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 09, 2014 |
Option Exercise |
$315.54 |
4,850 |
1,530,369 |
45,464 |
Feb 11, 2014, 07:55 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 09, 2014 |
Option Exercise |
$315.54 |
861 |
271,680 |
10,752 |
Feb 11, 2014, 07:52 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 08, 2014 |
Option Exercise |
$315.54 |
1,243 |
392,216 |
9,789 |
Feb 11, 2014, 07:52 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 09, 2014 |
Option Exercise |
$315.54 |
2,212 |
697,974 |
11,710 |
Feb 11, 2014, 07:49 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 08, 2014 |
Option Exercise |
$315.54 |
1,047 |
330,370 |
9,231 |
Feb 11, 2014, 07:49 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 08, 2014 |
Option Exercise |
$315.54 |
1,636 |
516,223 |
9,593 |
Feb 11, 2014, 07:47 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 08, 2014 |
Option Exercise |
$315.54 |
1,276 |
402,629 |
9,502 |
Feb 11, 2014, 07:45 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 09, 2014 |
Option Exercise |
$315.54 |
594 |
187,431 |
15,752 |
Feb 11, 2014, 07:43 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 08, 2014 |
Option Exercise |
$315.54 |
422 |
133,158 |
14,522 |
Feb 11, 2014, 07:43 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 08, 2014 |
Option Exercise |
$315.54 |
819 |
258,427 |
16,814 |
Feb 11, 2014, 06:07 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 09, 2014 |
Option Exercise |
$315.54 |
1,746 |
550,933 |
18,977 |
Feb 11, 2014, 06:07 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 09, 2014 |
Option Exercise |
$315.54 |
2,212 |
697,974 |
22,921 |
Feb 11, 2014, 06:07 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 08, 2014 |
Option Exercise |
$315.54 |
1,441 |
454,693 |
20,442 |
Feb 11, 2014, 06:07 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 04, 2014 |
Sale |
$299.01 |
1,655 |
494,862 |
0 |
Feb 05, 2014, 04:36 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 01, 2014 |
Option Exercise |
$312.64 |
808 |
252,613 |
1,655 |
Feb 03, 2014, 05:29 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 01, 2014 |
Option Exercise |
$312.64 |
1,969 |
615,588 |
7,761 |
Feb 03, 2014, 05:25 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 01, 2014 |
Option Exercise |
$312.64 |
1,701 |
531,801 |
8,396 |
Feb 03, 2014, 05:20 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 01, 2014 |
Option Exercise |
$312.64 |
1,971 |
616,213 |
8,073 |
Feb 03, 2014, 05:15 PM |
Rowinsky Eric K |
Director |
Jan 21, 2014 |
Sale |
$310.09 |
2,020 |
626,382 |
10,440 |
Jan 22, 2014, 04:49 PM |
SCHENK LYNN |
Director |
Jan 15, 2014 |
Sale |
$297.48 |
1,000 |
297,480 |
3,100 |
Jan 16, 2014, 10:27 AM |
YOUNG WILLIAM |
Director |
Jan 08, 2014 |
Sale |
$285.11 |
15,000 |
4,276,590 |
18,509 |
Jan 09, 2014, 04:24 PM |
PANGIA ROBERT W |
Director |
Jan 06, 2014 |
Option Exercise |
$47.55 |
6,250 |
297,187 |
20,253 |
Jan 07, 2014, 12:22 PM |
PANGIA ROBERT W |
Director |
Jan 06, 2014 |
Sale |
$278.03 |
6,250 |
1,737,687 |
14,003 |
Jan 07, 2014, 12:22 PM |
SHERWIN STEPHEN A |
Director |
Jan 02, 2014 |
Option Exercise |
$59.82 |
5,500 |
329,010 |
9,460 |
Jan 06, 2014, 11:19 AM |
SHERWIN STEPHEN A |
Director |
Jan 02, 2014 |
Sale |
$279.28 |
5,500 |
1,536,059 |
7,660 |
Jan 06, 2014, 11:19 AM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Dec 03, 2013 |
Option Exercise |
$287.76 |
394 |
113,377 |
14,106 |
Dec 05, 2013, 02:53 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Dec 04, 2013 |
Sale |
$285.90 |
439 |
125,510 |
13,667 |
Dec 05, 2013, 02:53 PM |
SCHENK LYNN |
Director |
Dec 02, 2013 |
Sale |
$291.71 |
1,000 |
291,710 |
4,100 |
Dec 02, 2013, 03:28 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Nov 22, 2013 |
Option Exercise |
$49.95 |
4,000 |
199,800 |
12,710 |
Nov 25, 2013, 02:11 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Nov 22, 2013 |
Sale |
$288.00 |
4,000 |
1,152,000 |
8,710 |
Nov 25, 2013, 02:11 PM |
SCHENK LYNN |
Director |
Nov 01, 2013 |
Sale |
$245.00 |
1,000 |
245,000 |
5,100 |
Nov 05, 2013, 12:18 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Nov 01, 2013 |
Sale |
$245.57 |
2,239 |
549,831 |
40,156 |
Nov 05, 2013, 12:13 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Oct 22, 2013 |
Option Exercise |
$60.56 |
15,030 |
910,217 |
29,530 |
Oct 23, 2013, 05:03 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Oct 22, 2013 |
Sale |
$250.11 |
15,030 |
3,759,123 |
14,500 |
Oct 23, 2013, 05:03 PM |
SCHENK LYNN |
Director |
Oct 01, 2013 |
Sale |
$242.85 |
1,000 |
242,850 |
6,100 |
Oct 02, 2013, 05:09 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Oct 01, 2013 |
Sale |
$242.85 |
2,239 |
543,741 |
42,395 |
Oct 02, 2013, 04:35 PM |
DiPietro Kenneth |
EVP Human Resources |
Sep 30, 2013 |
Sale |
$242.00 |
1,440 |
348,480 |
0 |
Oct 02, 2013, 01:36 PM |
Clancy Paul J |
Executive VP and CFO |
Sep 18, 2013 |
Option Exercise |
$49.65 |
26,785 |
1,329,875 |
33,872 |
Sep 19, 2013, 02:14 PM |
Clancy Paul J |
Executive VP and CFO |
Sep 18, 2013 |
Sale |
$245.00 |
26,785 |
6,562,325 |
7,087 |
Sep 19, 2013, 02:14 PM |
Clancy Paul J |
Executive VP and CFO |
Sep 16, 2013 |
Option Exercise |
$56.11 |
99,030 |
5,556,895 |
51,027 |
Sep 18, 2013, 04:34 PM |
Clancy Paul J |
Executive VP and CFO |
Sep 16, 2013 |
Sale |
$238.27 |
99,030 |
23,596,311 |
42,027 |
Sep 18, 2013, 04:34 PM |
Holtzman Steven H |
EVP Corporate Development |
Sep 17, 2013 |
Sale |
$238.98 |
3,501 |
836,669 |
4,885 |
Sep 18, 2013, 04:31 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Sep 16, 2013 |
Option Exercise |
$49.65 |
9,820 |
487,563 |
24,320 |
Sep 18, 2013, 04:28 PM |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Sep 16, 2013 |
Sale |
$240.10 |
9,820 |
2,357,821 |
14,500 |
Sep 18, 2013, 04:28 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Sep 16, 2013 |
Option Exercise |
$49.59 |
4,000 |
198,360 |
12,710 |
Sep 18, 2013, 04:26 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Sep 16, 2013 |
Sale |
$238.03 |
4,000 |
952,120 |
8,710 |
Sep 18, 2013, 04:26 PM |
SCHENK LYNN |
Director |
Sep 11, 2013 |
Sale |
$235.25 |
900 |
211,726 |
3,325 |
Sep 13, 2013, 02:33 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Sep 03, 2013 |
Sale |
$214.40 |
2,239 |
480,042 |
45,534 |
Sep 04, 2013, 04:52 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Aug 26, 2013 |
Sale |
$211.35 |
4,368 |
923,168 |
4,571 |
Aug 28, 2013, 12:30 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Aug 01, 2013 |
Sale |
$218.82 |
2,239 |
489,938 |
45,761 |
Aug 02, 2013, 10:55 AM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 16, 2013 |
Sale |
$223.94 |
2,239 |
501,402 |
48,000 |
Jul 18, 2013, 11:24 AM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 15, 2013 |
Option Exercise |
$224.33 |
20,011 |
4,489,068 |
60,177 |
Jul 16, 2013, 06:19 PM |
DENNER ALEXANDER J |
Director |
Jun 14, 2013 |
Sale |
$212.00 |
2,900 |
614,800 |
6,325 |
Jun 17, 2013, 03:46 PM |
PAPADOPOULOS STELIOS |
Director |
Jun 11, 2013 |
Sale |
$219.62 |
2,020 |
443,632 |
12,930 |
Jun 13, 2013, 04:27 PM |
Posner Brian S |
Director |
Jun 11, 2013 |
Sale |
$219.62 |
2,020 |
443,632 |
8,130 |
Jun 13, 2013, 04:23 PM |
SCHENK LYNN |
Director |
Jun 10, 2013 |
Sale |
$225.82 |
2,000 |
451,633 |
3,920 |
Jun 11, 2013, 03:55 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 03, 2013 |
Sale |
$234.16 |
1,598 |
374,188 |
48,911 |
Jun 04, 2013, 03:29 PM |
SHERWIN STEPHEN A |
Director |
Jun 03, 2013 |
Option Exercise |
$59.82 |
12,825 |
767,191 |
15,480 |
Jun 04, 2013, 03:26 PM |
SHERWIN STEPHEN A |
Director |
Jun 03, 2013 |
Sale |
$233.26 |
12,825 |
2,991,605 |
12,047 |
Jun 04, 2013, 03:26 PM |
Mulligan Richard |
Director |
May 29, 2013 |
Option Exercise |
$53.43 |
3,000 |
160,290 |
5,020 |
May 31, 2013, 12:27 PM |
DENNER ALEXANDER J |
Director |
May 29, 2013 |
Option Exercise |
$53.43 |
3,000 |
160,290 |
7,920 |
May 31, 2013, 12:26 PM |
Mulligan Richard |
Director |
May 28, 2013 |
Option Exercise |
$53.43 |
37,975 |
2,029,004 |
37,020 |
May 29, 2013, 05:16 PM |
Mulligan Richard |
Director |
May 28, 2013 |
Sale |
$240.69 |
37,975 |
9,140,100 |
36,120 |
May 29, 2013, 05:16 PM |
DENNER ALEXANDER J |
Director |
May 28, 2013 |
Option Exercise |
$53.43 |
37,975 |
2,029,004 |
39,920 |
May 29, 2013, 05:15 PM |
DENNER ALEXANDER J |
Director |
May 28, 2013 |
Sale |
$240.57 |
37,975 |
9,135,697 |
37,620 |
May 29, 2013, 05:15 PM |
PANGIA ROBERT W |
Director |
May 28, 2013 |
Sale |
$237.23 |
5,900 |
1,399,657 |
12,698 |
May 29, 2013, 05:12 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
May 03, 2013 |
Option Exercise |
$218.85 |
866 |
189,524 |
8,710 |
May 07, 2013, 01:36 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
May 03, 2013 |
Option Exercise |
$218.85 |
866 |
189,524 |
18,060 |
May 07, 2013, 01:33 PM |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2013 |
Option Exercise |
$214.33 |
114 |
24,434 |
375 |
May 03, 2013, 03:10 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
May 01, 2013 |
Sale |
$215.39 |
1,598 |
344,193 |
50,509 |
May 03, 2013, 03:07 PM |
Clancy Paul J |
Executive VP and CFO |
Apr 30, 2013 |
Sale |
$224.66 |
14,489 |
3,255,090 |
19,608 |
May 01, 2013, 03:45 PM |
Clancy Paul J |
Executive VP and CFO |
Apr 29, 2013 |
Sale |
$219.71 |
9,123 |
2,004,414 |
21,576 |
May 01, 2013, 03:45 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01, 2013 |
Sale |
$193.66 |
1,598 |
309,469 |
52,107 |
Apr 03, 2013, 12:31 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01, 2013 |
Sale |
$193.66 |
1,598 |
309,469 |
52,107 |
Apr 02, 2013, 01:23 PM |
Mulligan Richard |
Director |
Mar 22, 2013 |
Sale |
$176.88 |
2,900 |
512,952 |
2,020 |
Mar 25, 2013, 02:20 PM |
SHERWIN STEPHEN A |
Director |
Mar 22, 2013 |
Sale |
$176.88 |
1,500 |
265,320 |
2,655 |
Mar 25, 2013, 02:18 PM |
Posner Brian S |
Director |
Mar 18, 2013 |
Sale |
$174.81 |
4,500 |
786,645 |
10,150 |
Mar 19, 2013, 03:15 PM |
Mulligan Richard |
Director |
Mar 13, 2013 |
Sale |
$175.38 |
7,980 |
1,399,530 |
9,920 |
Mar 13, 2013, 02:56 PM |
PAPADOPOULOS STELIOS |
Director |
Mar 11, 2013 |
Option Exercise |
$58.44 |
46,675 |
2,727,463 |
49,950 |
Mar 12, 2013, 02:22 PM |
PAPADOPOULOS STELIOS |
Director |
Mar 11, 2013 |
Sale |
$172.26 |
46,675 |
8,040,003 |
18,916 |
Mar 12, 2013, 02:22 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Mar 01, 2013 |
Option Exercise |
$168.70 |
630 |
106,281 |
9,410 |
Mar 04, 2013, 04:42 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 01, 2013 |
Sale |
$165.30 |
1,598 |
264,149 |
53,705 |
Mar 04, 2013, 04:40 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 23, 2013 |
Option Exercise |
$164.40 |
1,227 |
201,719 |
18,759 |
Feb 26, 2013, 01:26 PM |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 23, 2013 |
Option Exercise |
$164.40 |
1,803 |
296,413 |
15,135 |
Feb 26, 2013, 01:25 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Feb 23, 2013 |
Option Exercise |
$164.40 |
722 |
118,697 |
10,040 |
Feb 26, 2013, 01:24 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 23, 2013 |
Option Exercise |
$164.40 |
2,021 |
332,252 |
30,699 |
Feb 26, 2013, 01:23 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 13, 2013 |
Sale |
$163.39 |
1,598 |
261,097 |
55,303 |
Feb 14, 2013, 02:59 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 09, 2013 |
Option Exercise |
$164.44 |
861 |
141,583 |
5,511 |
Feb 12, 2013, 05:26 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 08, 2013 |
Option Exercise |
$164.44 |
831 |
136,650 |
4,548 |
Feb 12, 2013, 05:26 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 09, 2013 |
Option Exercise |
$164.44 |
1,731 |
284,646 |
28,439 |
Feb 12, 2013, 05:24 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 08, 2013 |
Option Exercise |
$164.44 |
899 |
147,832 |
25,478 |
Feb 12, 2013, 05:24 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 08, 2013 |
Option Exercise |
$164.44 |
940 |
154,574 |
8,386 |
Feb 12, 2013, 05:22 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Feb 08, 2013 |
Option Exercise |
$164.44 |
523 |
86,002 |
8,236 |
Feb 12, 2013, 05:20 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Feb 09, 2013 |
Option Exercise |
$164.44 |
893 |
146,845 |
9,233 |
Feb 12, 2013, 05:20 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 09, 2013 |
Option Exercise |
$164.44 |
1,275 |
209,661 |
13,117 |
Feb 12, 2013, 05:12 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 08, 2013 |
Option Exercise |
$164.44 |
702 |
115,437 |
10,483 |
Feb 12, 2013, 05:12 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 08, 2013 |
Option Exercise |
$164.44 |
1,133 |
186,311 |
14,532 |
Feb 12, 2013, 05:10 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 09, 2013 |
Option Exercise |
$164.44 |
1,836 |
301,912 |
17,388 |
Feb 12, 2013, 05:10 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 08, 2013 |
Option Exercise |
$164.44 |
1,252 |
205,879 |
8,939 |
Feb 12, 2013, 05:08 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 10, 2013 |
Option Exercise |
$164.44 |
8,890 |
1,461,872 |
56,901 |
Feb 12, 2013, 05:05 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 09, 2013 |
Option Exercise |
$164.44 |
3,723 |
612,210 |
46,958 |
Feb 12, 2013, 05:05 PM |
PANGIA ROBERT W |
Director |
Feb 06, 2013 |
Option Exercise |
$66.29 |
2,500 |
165,725 |
21,098 |
Feb 07, 2013, 01:58 PM |
PANGIA ROBERT W |
Director |
Feb 06, 2013 |
Sale |
$165.55 |
2,500 |
413,875 |
18,598 |
Feb 07, 2013, 01:58 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Feb 06, 2013 |
Option Exercise |
$49.65 |
10,000 |
496,500 |
17,653 |
Feb 07, 2013, 01:55 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Feb 06, 2013 |
Sale |
$165.55 |
10,000 |
1,655,500 |
7,653 |
Feb 07, 2013, 01:55 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 01, 2013 |
Option Exercise |
$157.30 |
1,679 |
264,107 |
7,185 |
Feb 05, 2013, 06:23 PM |
Holtzman Steven H |
EVP Corporate Development |
Feb 01, 2013 |
Option Exercise |
$157.30 |
1,678 |
263,949 |
6,982 |
Feb 05, 2013, 04:25 PM |
DiPietro Kenneth |
EVP Human Resources |
Feb 01, 2013 |
Option Exercise |
$157.30 |
711 |
111,840 |
1,440 |
Feb 05, 2013, 04:23 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 01, 2013 |
Option Exercise |
$157.30 |
1,491 |
234,534 |
3,095 |
Feb 05, 2013, 04:22 PM |
DENNER ALEXANDER J |
Director |
Dec 26, 2012 |
Sale |
$148.89 |
3,989 |
593,914 |
8,911 |
Dec 28, 2012, 10:15 AM |
DENNER ALEXANDER J |
Director |
Dec 27, 2012 |
Sale |
$148.36 |
3,991 |
592,086 |
6,220 |
Dec 28, 2012, 10:15 AM |
SCANGOS GEORGE A |
Chief Executive Officer |
Nov 01, 2012 |
Sale |
$139.42 |
2,472 |
344,640 |
52,898 |
Nov 02, 2012, 03:49 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Oct 01, 2012 |
Sale |
$149.16 |
3,654 |
545,031 |
54,142 |
Oct 02, 2012, 01:10 PM |
PANGIA ROBERT W |
Director |
Sep 17, 2012 |
Option Exercise |
$66.29 |
5,000 |
331,450 |
23,598 |
Sep 18, 2012, 05:26 PM |
PANGIA ROBERT W |
Director |
Sep 17, 2012 |
Sale |
$155.00 |
5,000 |
775,000 |
18,598 |
Sep 18, 2012, 05:26 PM |
PANGIA ROBERT W |
Director |
Sep 06, 2012 |
Option Exercise |
$66.29 |
5,000 |
331,450 |
23,598 |
Sep 10, 2012, 02:20 PM |
PANGIA ROBERT W |
Director |
Sep 06, 2012 |
Sale |
$150.00 |
5,000 |
750,000 |
18,598 |
Sep 10, 2012, 02:20 PM |
SHERWIN STEPHEN A |
Director |
Sep 04, 2012 |
Sale |
$145.90 |
2,000 |
291,800 |
4,155 |
Sep 05, 2012, 03:20 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Sep 04, 2012 |
Sale |
$145.90 |
3,654 |
533,119 |
57,796 |
Sep 05, 2012, 03:17 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Aug 02, 2012 |
Sale |
$142.99 |
1,165 |
166,583 |
9,020 |
Aug 03, 2012, 11:12 AM |
SCANGOS GEORGE A |
Chief Executive Officer |
Aug 01, 2012 |
Sale |
$146.30 |
3,655 |
534,727 |
61,450 |
Aug 02, 2012, 03:24 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Jul 27, 2012 |
Option Exercise |
$57.04 |
58,070 |
3,312,157 |
68,255 |
Jul 30, 2012, 02:58 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Jul 27, 2012 |
Sale |
$150.00 |
58,070 |
8,710,500 |
10,185 |
Jul 30, 2012, 02:58 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 17, 2012 |
Sale |
$146.04 |
2,472 |
361,011 |
66,333 |
Jul 18, 2012, 03:35 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 16, 2012 |
Option Exercise |
$144.61 |
17,679 |
2,556,560 |
76,357 |
Jul 17, 2012, 01:03 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 02, 2012 |
Sale |
$143.50 |
1,183 |
169,761 |
63,917 |
Jul 03, 2012, 10:40 AM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Jun 19, 2012 |
Option Exercise |
$49.59 |
10,000 |
495,900 |
17,653 |
Jun 21, 2012, 11:41 AM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Jun 19, 2012 |
Sale |
$143.00 |
10,000 |
1,430,000 |
7,653 |
Jun 21, 2012, 11:41 AM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Jun 15, 2012 |
Option Exercise |
$47.87 |
49,800 |
2,383,838 |
59,985 |
Jun 18, 2012, 01:53 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Jun 15, 2012 |
Sale |
$140.00 |
49,800 |
6,972,000 |
10,185 |
Jun 18, 2012, 01:53 PM |
PANGIA ROBERT W |
Director |
Jun 15, 2012 |
Option Exercise |
$36.94 |
5,000 |
184,700 |
23,598 |
Jun 18, 2012, 01:50 PM |
PANGIA ROBERT W |
Director |
Jun 15, 2012 |
Sale |
$140.00 |
5,000 |
700,000 |
18,598 |
Jun 18, 2012, 01:50 PM |
Posner Brian S |
Director |
Jun 07, 2012 |
Option Exercise |
$71.38 |
2,500 |
178,450 |
15,130 |
Jun 11, 2012, 11:22 AM |
Posner Brian S |
Director |
Jun 07, 2012 |
Sale |
$135.00 |
2,500 |
337,500 |
12,630 |
Jun 11, 2012, 11:22 AM |
PANGIA ROBERT W |
Director |
Jun 04, 2012 |
Option Exercise |
$36.94 |
5,000 |
184,700 |
21,578 |
Jun 05, 2012, 03:45 PM |
PANGIA ROBERT W |
Director |
Jun 04, 2012 |
Sale |
$130.00 |
5,000 |
650,000 |
16,578 |
Jun 05, 2012, 03:45 PM |
SHERWIN STEPHEN A |
Director |
Jun 04, 2012 |
Sale |
$126.45 |
2,500 |
316,125 |
4,135 |
Jun 05, 2012, 03:43 PM |
Posner Brian S |
Director |
Jun 04, 2012 |
Option Exercise |
$71.38 |
2,400 |
171,312 |
15,030 |
Jun 05, 2012, 03:41 PM |
Posner Brian S |
Director |
Jun 04, 2012 |
Sale |
$126.45 |
2,400 |
303,480 |
12,630 |
Jun 05, 2012, 03:41 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
Jun 04, 2012 |
Sale |
$126.45 |
1,068 |
135,049 |
7,653 |
Jun 05, 2012, 03:39 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 01, 2012 |
Sale |
$128.63 |
1,183 |
152,169 |
65,100 |
Jun 04, 2012, 04:26 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
May 03, 2012 |
Option Exercise |
$134.26 |
765 |
102,709 |
12,178 |
May 04, 2012, 02:03 PM |
Pawlicki Raymond |
SVP, Chief Information Officer |
May 03, 2012 |
Option Exercise |
$134.26 |
765 |
102,709 |
8,721 |
May 04, 2012, 02:02 PM |
SCHENK LYNN |
Director |
May 02, 2012 |
Option Exercise |
$53.43 |
5,975 |
319,244 |
8,875 |
May 03, 2012, 04:46 PM |
SCHENK LYNN |
Director |
May 02, 2012 |
Sale |
$135.00 |
5,975 |
806,625 |
2,900 |
May 03, 2012, 04:46 PM |
SCHENK LYNN |
Director |
May 02, 2012 |
Sale |
$135.00 |
8,480 |
1,144,800 |
7,100 |
May 03, 2012, 04:46 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
May 02, 2012 |
Option Exercise |
$44.73 |
20,000 |
894,600 |
30,185 |
May 03, 2012, 04:34 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
May 02, 2012 |
Sale |
$135.00 |
20,000 |
2,700,000 |
10,185 |
May 03, 2012, 04:34 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Apr 25, 2012 |
Option Exercise |
$44.73 |
16,764 |
749,854 |
26,949 |
Apr 26, 2012, 03:44 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Apr 25, 2012 |
Sale |
$130.00 |
16,764 |
2,179,320 |
10,185 |
Apr 26, 2012, 03:44 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Apr 04, 2012 |
Option Exercise |
$44.73 |
3,236 |
144,746 |
13,421 |
Apr 06, 2012, 03:28 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Apr 04, 2012 |
Sale |
$130.00 |
3,236 |
420,680 |
10,185 |
Apr 06, 2012, 03:28 PM |
PANGIA ROBERT W |
Director |
Mar 08, 2012 |
Option Exercise |
$35.21 |
7,500 |
264,050 |
21,578 |
Mar 12, 2012, 03:02 PM |
PANGIA ROBERT W |
Director |
Mar 08, 2012 |
Sale |
$120.00 |
7,500 |
900,000 |
16,578 |
Mar 12, 2012, 03:02 PM |
Gagnon Robert E. |
Vice President, Finance |
Feb 29, 2012 |
Sale |
$115.51 |
717 |
82,821 |
4,356 |
Mar 01, 2012, 03:23 PM |
Gagnon Robert E. |
Vice President, Finance |
Feb 28, 2012 |
Sale |
$115.03 |
835 |
96,050 |
4,716 |
Mar 01, 2012, 03:23 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 27, 2012 |
Sale |
$115.43 |
4,255 |
491,155 |
12,302 |
Feb 28, 2012, 04:01 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 23, 2012 |
Option Exercise |
$116.70 |
1,413 |
164,897 |
19,186 |
Feb 27, 2012, 04:20 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 24, 2012 |
Option Exercise |
$116.39 |
2,601 |
302,730 |
15,747 |
Feb 27, 2012, 04:20 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 24, 2012 |
Sale |
$115.53 |
2,145 |
247,812 |
17,447 |
Feb 27, 2012, 04:20 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 24, 2012 |
Option Exercise |
$116.39 |
1,578 |
183,663 |
13,506 |
Feb 27, 2012, 04:19 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 23, 2012 |
Option Exercise |
$116.70 |
1,085 |
126,619 |
14,291 |
Feb 27, 2012, 04:19 PM |
Gagnon Robert E. |
Vice President, Finance |
Feb 24, 2012 |
Option Exercise |
$116.39 |
334 |
38,874 |
5,719 |
Feb 27, 2012, 04:18 PM |
Gagnon Robert E. |
Vice President, Finance |
Feb 23, 2012 |
Option Exercise |
$116.70 |
388 |
45,280 |
5,885 |
Feb 27, 2012, 04:18 PM |
Gagnon Robert E. |
Vice President, Finance |
Feb 24, 2012 |
Option Exercise |
$49.65 |
1,054 |
52,331 |
6,939 |
Feb 27, 2012, 04:18 PM |
Gagnon Robert E. |
Vice President, Finance |
Feb 24, 2012 |
Sale |
$115.53 |
1,054 |
121,769 |
5,885 |
Feb 27, 2012, 04:18 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 24, 2012 |
Option Exercise |
$116.39 |
2,786 |
324,263 |
25,012 |
Feb 27, 2012, 04:17 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 23, 2012 |
Option Exercise |
$116.70 |
1,786 |
208,426 |
26,398 |
Feb 27, 2012, 04:17 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 15, 2011 |
Option Exercise |
$104.00 |
8,791 |
914,264 |
54,374 |
Feb 22, 2012, 12:03 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 14, 2012 |
Sale |
$118.61 |
1,247 |
147,907 |
0 |
Feb 16, 2012, 02:39 PM |
Gagnon Robert E. |
Vice President, Finance |
Feb 14, 2012 |
Sale |
$118.61 |
560 |
66,422 |
5,050 |
Feb 16, 2012, 02:37 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 13, 2012 |
Sale |
$118.01 |
2,842 |
335,384 |
16,777 |
Feb 14, 2012, 03:58 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 09, 2012 |
Option Exercise |
$117.78 |
579 |
68,195 |
1,247 |
Feb 14, 2012, 03:57 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 09, 2012 |
Option Exercise |
$117.78 |
1,504 |
177,141 |
12,776 |
Feb 13, 2012, 04:28 PM |
Gagnon Robert E. |
Vice President, Finance |
Feb 09, 2012 |
Option Exercise |
$117.78 |
301 |
35,452 |
5,610 |
Feb 13, 2012, 04:27 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 09, 2012 |
Option Exercise |
$117.78 |
1,257 |
148,049 |
19,619 |
Feb 13, 2012, 04:26 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 10, 2012 |
Option Exercise |
$118.14 |
7,007 |
827,807 |
66,283 |
Feb 13, 2012, 04:24 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 09, 2012 |
Option Exercise |
$117.78 |
1,957 |
230,495 |
23,903 |
Feb 13, 2012, 04:21 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 06, 2012 |
Sale |
$121.03 |
3,110 |
376,403 |
0 |
Feb 08, 2012, 03:07 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 01, 2012 |
Option Exercise |
$52.95 |
21,400 |
1,133,088 |
42,568 |
Feb 03, 2012, 02:56 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 01, 2012 |
Sale |
$120.00 |
21,400 |
2,568,000 |
29,568 |
Feb 03, 2012, 02:56 PM |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 01, 2012 |
Option Exercise |
$121.26 |
1,656 |
200,807 |
3,906 |
Feb 03, 2012, 02:55 PM |
Holtzman Steven H |
EVP Corp Devel and Strategy |
Feb 01, 2012 |
Option Exercise |
$121.26 |
1,658 |
201,049 |
3,501 |
Feb 03, 2012, 02:54 PM |
Granata Francesco |
EVP Global Commercial Operatio |
Feb 01, 2012 |
Option Exercise |
$121.26 |
1,669 |
202,383 |
3,529 |
Feb 03, 2012, 02:53 PM |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 01, 2012 |
Option Exercise |
$121.26 |
1,477 |
179,101 |
3,110 |
Feb 03, 2012, 02:52 PM |
LEAMING NANCY |
Director |
Feb 01, 2012 |
Option Exercise |
$59.17 |
5,700 |
337,269 |
12,035 |
Feb 03, 2012, 02:51 PM |
LEAMING NANCY |
Director |
Feb 01, 2012 |
Sale |
$120.00 |
5,700 |
684,000 |
6,335 |
Feb 03, 2012, 02:51 PM |
LEAMING NANCY |
Director |
Jan 20, 2012 |
Option Exercise |
$55.97 |
3,000 |
167,910 |
9,335 |
Jan 24, 2012, 03:55 PM |
LEAMING NANCY |
Director |
Jan 20, 2012 |
Sale |
$118.00 |
3,000 |
354,000 |
6,335 |
Jan 24, 2012, 03:55 PM |
LEAMING NANCY |
Director |
Jan 06, 2012 |
Option Exercise |
$55.97 |
3,000 |
167,910 |
9,335 |
Jan 09, 2012, 03:54 PM |
LEAMING NANCY |
Director |
Jan 06, 2012 |
Sale |
$116.00 |
3,000 |
348,000 |
6,335 |
Jan 09, 2012, 03:54 PM |
Rowinsky Eric K |
Director |
Jan 06, 2012 |
Option Exercise |
$59.82 |
12,992 |
777,181 |
20,802 |
Jan 09, 2012, 03:52 PM |
Rowinsky Eric K |
Director |
Jan 06, 2012 |
Sale |
$116.00 |
12,992 |
1,507,072 |
9,135 |
Jan 09, 2012, 03:52 PM |
LEAMING NANCY |
Director |
Jan 03, 2012 |
Option Exercise |
$55.97 |
4,000 |
223,880 |
10,335 |
Jan 04, 2012, 01:27 PM |
LEAMING NANCY |
Director |
Jan 03, 2012 |
Sale |
$114.00 |
4,000 |
456,000 |
6,335 |
Jan 04, 2012, 01:27 PM |
Clancy Paul J |
Executive VP and CFO |
Jan 03, 2012 |
Sale |
$112.35 |
20,244 |
2,274,398 |
26,742 |
Jan 04, 2012, 01:24 PM |
SHERWIN STEPHEN A |
Director |
Dec 19, 2011 |
Sale |
$110.88 |
2,500 |
277,200 |
6,635 |
Dec 20, 2011, 03:10 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Dec 06, 2011 |
Sale |
$112.31 |
795 |
89,286 |
5,050 |
Dec 08, 2011, 02:05 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Dec 01, 2011 |
Option Exercise |
$116.48 |
371 |
43,214 |
5,845 |
Dec 02, 2011, 02:10 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Nov 09, 2011 |
Sale |
$112.04 |
796 |
89,184 |
6,216 |
Nov 14, 2011, 11:26 AM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Nov 02, 2011 |
Option Exercise |
$113.43 |
371 |
42,083 |
7,012 |
Nov 04, 2011, 11:50 AM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 01, 2011 |
Option Exercise |
$72.87 |
2,175 |
158,492 |
11,763 |
Nov 03, 2011, 10:52 AM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 01, 2011 |
Sale |
$114.37 |
2,175 |
248,755 |
9,588 |
Nov 03, 2011, 10:52 AM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Oct 05, 2011 |
Sale |
$97.66 |
252 |
24,610 |
7,383 |
Oct 07, 2011, 01:48 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Oct 01, 2011 |
Option Exercise |
$93.15 |
118 |
10,992 |
7,635 |
Oct 04, 2011, 06:28 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Oct 03, 2011 |
Option Exercise |
$49.59 |
778 |
38,581 |
8,413 |
Oct 04, 2011, 06:28 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Oct 03, 2011 |
Sale |
$92.55 |
778 |
72,004 |
7,635 |
Oct 04, 2011, 06:28 PM |
YOUNG WILLIAM |
Director |
Sep 27, 2011 |
Option Exercise |
$51.38 |
33,250 |
1,708,441 |
60,109 |
Sep 29, 2011, 01:01 PM |
YOUNG WILLIAM |
Director |
Sep 27, 2011 |
Sale |
$96.14 |
33,250 |
3,196,655 |
26,859 |
Sep 29, 2011, 01:01 PM |
LEAMING NANCY |
Director |
Sep 16, 2011 |
Sale |
$100.00 |
3,085 |
308,500 |
6,335 |
Sep 19, 2011, 05:18 PM |
YOUNG WILLIAM |
Director |
Sep 01, 2011 |
Option Exercise |
$46.68 |
35,000 |
1,633,775 |
61,859 |
Sep 02, 2011, 12:45 PM |
YOUNG WILLIAM |
Director |
Sep 01, 2011 |
Sale |
$95.00 |
35,000 |
3,325,000 |
26,859 |
Sep 02, 2011, 12:45 PM |
Posner Brian S |
Director |
Aug 29, 2011 |
Option Exercise |
$71.38 |
15,000 |
1,070,700 |
27,630 |
Aug 31, 2011, 11:44 AM |
Posner Brian S |
Director |
Aug 29, 2011 |
Sale |
$92.53 |
15,000 |
1,387,894 |
12,630 |
Aug 31, 2011, 11:44 AM |
YOUNG WILLIAM |
Director |
Aug 29, 2011 |
Option Exercise |
$68.15 |
10,000 |
681,500 |
36,859 |
Aug 31, 2011, 11:42 AM |
YOUNG WILLIAM |
Director |
Aug 29, 2011 |
Sale |
$92.58 |
10,000 |
925,784 |
26,859 |
Aug 31, 2011, 11:42 AM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Aug 01, 2011 |
Option Exercise |
$102.90 |
835 |
85,922 |
18,130 |
Aug 03, 2011, 11:24 AM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Aug 02, 2011 |
Sale |
$102.04 |
1,165 |
118,877 |
16,965 |
Aug 03, 2011, 11:24 AM |
Clancy Paul J |
Executive VP and CFO |
Aug 01, 2011 |
Option Exercise |
$102.90 |
835 |
85,922 |
41,412 |
Aug 03, 2011, 11:23 AM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 20, 2011 |
Sale |
$106.51 |
12,347 |
1,315,035 |
64,164 |
Jul 21, 2011, 02:30 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 14, 2011 |
Option Exercise |
$104.00 |
8,791 |
914,264 |
54,374 |
Jul 19, 2011, 04:29 PM |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 15, 2011 |
Option Exercise |
$104.00 |
8,911 |
926,744 |
66,804 |
Jul 19, 2011, 04:29 PM |
Granata Francesco |
EVP Global Commercial Operatio |
Jul 01, 2011 |
Sale |
$107.52 |
2,901 |
311,918 |
0 |
Jul 01, 2011, 01:51 PM |
LEAMING NANCY |
Director |
Jun 14, 2011 |
Sale |
$92.62 |
2,300 |
213,022 |
9,420 |
Jun 14, 2011, 05:20 PM |
Posner Brian S |
Director |
May 25, 2011 |
Option Exercise |
$67.25 |
25,975 |
1,746,844 |
35,705 |
May 27, 2011, 03:15 PM |
Posner Brian S |
Director |
May 25, 2011 |
Sale |
$94.09 |
25,975 |
2,444,027 |
22,900 |
May 27, 2011, 03:15 PM |
LEAMING NANCY |
Director |
May 26, 2011 |
Option Exercise |
$55.51 |
33,175 |
1,841,628 |
41,995 |
May 27, 2011, 03:13 PM |
LEAMING NANCY |
Director |
May 26, 2011 |
Sale |
$93.05 |
33,175 |
3,087,085 |
13,451 |
May 27, 2011, 03:13 PM |
PANGIA ROBERT W |
Director |
May 26, 2011 |
Option Exercise |
$56.88 |
15,000 |
853,200 |
29,080 |
May 27, 2011, 03:11 PM |
PANGIA ROBERT W |
Director |
May 26, 2011 |
Sale |
$93.11 |
15,000 |
1,396,647 |
16,280 |
May 27, 2011, 03:11 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
May 06, 2011 |
Sale |
$96.13 |
967 |
92,960 |
7,753 |
May 09, 2011, 04:38 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
May 03, 2011 |
Option Exercise |
$97.99 |
450 |
44,095 |
8,935 |
May 04, 2011, 02:53 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
May 04, 2011 |
Sale |
$96.03 |
215 |
20,646 |
8,720 |
May 04, 2011, 02:53 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
May 03, 2011 |
Option Exercise |
$97.99 |
765 |
74,962 |
9,588 |
May 04, 2011, 02:51 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
May 01, 2011 |
Option Exercise |
$97.65 |
101 |
9,863 |
9,385 |
May 03, 2011, 01:03 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
May 02, 2011 |
Sale |
$97.20 |
20,993 |
2,040,497 |
35,834 |
May 03, 2011, 01:01 PM |
Clancy Paul J |
Executive VP and CFO |
Apr 28, 2011 |
Option Exercise |
$41.18 |
14,766 |
608,119 |
57,202 |
Apr 29, 2011, 03:03 PM |
Clancy Paul J |
Executive VP and CFO |
Apr 28, 2011 |
Sale |
$98.91 |
19,716 |
1,950,088 |
48,497 |
Apr 29, 2011, 03:03 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 21, 2011 |
Option Exercise |
$72.87 |
4,350 |
316,985 |
14,703 |
Apr 25, 2011, 02:02 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 21, 2011 |
Sale |
$100.00 |
4,350 |
435,000 |
10,353 |
Apr 25, 2011, 02:02 PM |
SCHENK LYNN |
Director |
Apr 20, 2011 |
Option Exercise |
$61.84 |
37,275 |
2,304,947 |
35,255 |
Apr 21, 2011, 04:41 PM |
SCHENK LYNN |
Director |
Apr 20, 2011 |
Sale |
$85.22 |
37,275 |
3,176,461 |
7,980 |
Apr 21, 2011, 04:41 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 13, 2011 |
Option Exercise |
$56.73 |
36,234 |
2,055,646 |
46,587 |
Apr 15, 2011, 11:50 AM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 13, 2011 |
Sale |
$80.00 |
36,234 |
2,898,720 |
10,353 |
Apr 15, 2011, 11:50 AM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 11, 2011 |
Option Exercise |
$47.92 |
6,900 |
330,648 |
17,253 |
Apr 13, 2011, 10:14 AM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Apr 11, 2011 |
Sale |
$78.00 |
6,900 |
538,200 |
10,353 |
Apr 13, 2011, 10:14 AM |
Clancy Paul J |
Executive VP and CFO |
Mar 05, 2011 |
Option Exercise |
$71.15 |
25,888 |
1,841,931 |
47,197 |
Apr 08, 2011, 10:38 AM |
Clancy Paul J |
Executive VP and CFO |
Mar 05, 2011 |
Option Exercise |
$58.99 |
28,750 |
1,695,963 |
73,085 |
Apr 08, 2011, 10:38 AM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Mar 31, 2011 |
Option Exercise |
$43.50 |
2,840 |
123,540 |
12,658 |
Apr 01, 2011, 03:20 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Mar 31, 2011 |
Sale |
$73.00 |
2,840 |
207,320 |
9,818 |
Apr 01, 2011, 03:20 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Mar 01, 2011 |
Option Exercise |
$49.65 |
6,250 |
310,313 |
23,962 |
Mar 03, 2011, 03:17 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Mar 01, 2011 |
Sale |
$68.62 |
6,250 |
428,875 |
17,712 |
Mar 03, 2011, 03:17 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Mar 02, 2011 |
Sale |
$70.10 |
7,511 |
526,552 |
13,633 |
Mar 03, 2011, 03:17 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Mar 02, 2011 |
Sale |
$70.10 |
4,041 |
283,259 |
12,401 |
Mar 03, 2011, 03:10 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Mar 02, 2011 |
Sale |
$70.02 |
1,402 |
98,164 |
10,788 |
Mar 03, 2011, 03:08 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 24, 2011 |
Option Exercise |
$67.26 |
1,980 |
133,175 |
40,953 |
Feb 28, 2011, 03:41 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 24, 2011 |
Option Exercise |
$67.26 |
2,164 |
145,551 |
45,401 |
Feb 28, 2011, 03:39 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 24, 2011 |
Option Exercise |
$67.26 |
335 |
22,532 |
11,056 |
Feb 28, 2011, 03:36 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 24, 2011 |
Option Exercise |
$67.26 |
2,156 |
145,013 |
18,707 |
Feb 28, 2011, 03:34 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 24, 2011 |
Option Exercise |
$67.26 |
1,202 |
80,847 |
14,463 |
Feb 28, 2011, 03:32 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 23, 2011 |
Option Exercise |
$66.76 |
680 |
45,397 |
15,190 |
Feb 25, 2011, 03:56 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 23, 2011 |
Option Exercise |
$66.76 |
1,119 |
74,704 |
46,711 |
Feb 25, 2011, 03:55 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 23, 2011 |
Option Exercise |
$66.76 |
320 |
21,363 |
11,284 |
Feb 25, 2011, 03:54 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 24, 2011 |
Option Exercise |
$49.65 |
1,054 |
52,331 |
12,277 |
Feb 25, 2011, 03:54 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 24, 2011 |
Sale |
$66.99 |
1,054 |
70,606 |
11,223 |
Feb 25, 2011, 03:54 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 23, 2011 |
Option Exercise |
$66.76 |
1,598 |
106,682 |
20,171 |
Feb 25, 2011, 03:53 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 25, 2011 |
Option Exercise |
$49.31 |
9,725 |
479,540 |
29,593 |
Feb 25, 2011, 03:53 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 25, 2011 |
Sale |
$68.20 |
9,725 |
663,245 |
19,868 |
Feb 25, 2011, 03:53 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 23, 2011 |
Option Exercise |
$66.76 |
999 |
66,693 |
42,128 |
Feb 25, 2011, 03:51 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 17, 2011 |
Sale |
$67.10 |
732 |
49,115 |
10,537 |
Feb 18, 2011, 03:09 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 17, 2011 |
Sale |
$67.08 |
3,194 |
214,242 |
16,436 |
Feb 18, 2011, 03:07 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 17, 2011 |
Sale |
$67.08 |
1,843 |
123,620 |
13,603 |
Feb 18, 2011, 03:06 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Feb 12, 2011 |
Option Exercise |
$65.83 |
1,486 |
97,823 |
19,630 |
Feb 15, 2011, 02:31 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Feb 12, 2011 |
Option Exercise |
$65.83 |
341 |
22,448 |
11,269 |
Feb 15, 2011, 02:29 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 12, 2011 |
Option Exercise |
$65.83 |
910 |
59,905 |
15,446 |
Feb 15, 2011, 02:27 PM |
Clancy Paul J |
Executive VP and CFO |
Feb 12, 2011 |
Option Exercise |
$65.83 |
1,686 |
110,989 |
44,097 |
Feb 15, 2011, 02:26 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Feb 12, 2011 |
Option Exercise |
$65.83 |
1,515 |
99,732 |
39,793 |
Feb 15, 2011, 02:24 PM |
Granata Francesco |
EVP Global Commercial Operatio |
Feb 01, 2011 |
Option Exercise |
$65.49 |
1,385 |
90,704 |
3,162 |
Feb 03, 2011, 05:14 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Jan 20, 2011 |
Option Exercise |
$49.65 |
6,250 |
310,313 |
27,366 |
Jan 24, 2011, 02:59 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Jan 20, 2011 |
Sale |
$68.62 |
6,250 |
428,875 |
21,116 |
Jan 24, 2011, 02:59 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Jan 04, 2011 |
Option Exercise |
$46.07 |
4,307 |
198,415 |
12,514 |
Jan 05, 2011, 02:45 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Jan 04, 2011 |
Sale |
$66.57 |
5,103 |
339,690 |
10,814 |
Jan 05, 2011, 02:45 PM |
YOUNG WILLIAM |
Director |
Dec 31, 2010 |
Option Exercise |
$67.05 |
13,256 |
888,815 |
21,059 |
Jan 04, 2011, 03:58 PM |
YOUNG WILLIAM |
Director |
Dec 31, 2010 |
Option Exercise |
$59.25 |
15,000 |
888,750 |
34,315 |
Jan 04, 2011, 03:58 PM |
SCHENK LYNN |
Director |
Dec 30, 2010 |
Option Exercise |
$59.25 |
15,000 |
888,750 |
22,980 |
Jan 03, 2011, 09:57 AM |
SCHENK LYNN |
Director |
Dec 30, 2010 |
Sale |
$66.80 |
15,000 |
1,001,988 |
7,980 |
Jan 03, 2011, 09:57 AM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 17, 2010 |
Option Exercise |
$49.31 |
19,450 |
959,080 |
40,566 |
Dec 21, 2010, 03:32 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 17, 2010 |
Sale |
$68.20 |
19,450 |
1,326,490 |
21,116 |
Dec 21, 2010, 03:32 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Dec 06, 2010 |
Sale |
$66.53 |
796 |
52,957 |
11,610 |
Dec 07, 2010, 05:14 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 03, 2010 |
Option Exercise |
$44.24 |
1,907 |
84,366 |
23,023 |
Dec 07, 2010, 05:13 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 07, 2010 |
Option Exercise |
$44.24 |
28,093 |
1,242,834 |
49,209 |
Dec 07, 2010, 05:13 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 07, 2010 |
Sale |
$67.20 |
28,093 |
1,887,850 |
21,116 |
Dec 07, 2010, 05:13 PM |
SCHNEIER CRAIG ERIC |
EVP, HR, Public Affairs & Comm |
Dec 03, 2010 |
Sale |
$67.20 |
1,907 |
128,150 |
21,116 |
Dec 07, 2010, 05:13 PM |
Gagnon Robert E. |
Chief Acct Officer VP & Contr |
Dec 01, 2010 |
Option Exercise |
$65.37 |
371 |
24,252 |
12,406 |
Dec 03, 2010, 01:46 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 09, 2010 |
Sale |
$62.87 |
773 |
48,597 |
16,356 |
Nov 10, 2010, 02:21 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 09, 2010 |
Sale |
$62.87 |
773 |
48,597 |
16,356 |
Nov 10, 2010, 02:21 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 01, 2010 |
Option Exercise |
$62.55 |
360 |
22,518 |
17,894 |
Nov 03, 2010, 01:50 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 01, 2010 |
Option Exercise |
$62.55 |
360 |
22,518 |
17,894 |
Nov 03, 2010, 01:50 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 02, 2010 |
Sale |
$63.04 |
765 |
48,228 |
17,129 |
Nov 03, 2010, 01:50 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Nov 02, 2010 |
Sale |
$63.04 |
765 |
48,228 |
17,129 |
Nov 03, 2010, 01:50 PM |
PANGIA ROBERT W |
Director |
Oct 28, 2010 |
Option Exercise |
$59.25 |
15,000 |
888,750 |
29,080 |
Oct 29, 2010, 02:27 PM |
PANGIA ROBERT W |
Director |
Oct 28, 2010 |
Sale |
$64.00 |
15,000 |
960,000 |
14,080 |
Oct 29, 2010, 02:27 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Oct 28, 2010 |
Option Exercise |
$33.97 |
6,900 |
234,393 |
25,154 |
Oct 29, 2010, 02:25 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Oct 28, 2010 |
Option Exercise |
$33.97 |
6,900 |
234,393 |
25,154 |
Oct 29, 2010, 02:25 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Oct 28, 2010 |
Sale |
$63.00 |
6,900 |
434,700 |
18,254 |
Oct 29, 2010, 02:25 PM |
Cox John |
EVP Pharmaceutical Oper & Tech |
Oct 28, 2010 |
Sale |
$63.00 |
6,900 |
434,700 |
18,254 |
Oct 29, 2010, 02:25 PM |
MacLean Michael F |
SVP, Chief Accounting Officer |
Oct 01, 2010 |
Option Exercise |
$56.53 |
953 |
53,873 |
10,681 |
Oct 04, 2010, 04:14 PM |
Clancy Paul J |
Executive VP and CFO |
Sep 04, 2010 |
Option Exercise |
$56.24 |
1,114 |
62,651 |
45,783 |
Sep 07, 2010, 04:05 PM |
DORSA CAROLINE |
Director |
Aug 13, 2010 |
Buy |
$56.41 |
177 |
9,985 |
8,243 |
Aug 17, 2010, 04:35 PM |
MacLean Michael F |
SVP, Chief Accounting Officer |
Aug 02, 2010 |
Sale |
$56.85 |
9,542 |
542,457 |
20,494 |
Aug 03, 2010, 04:03 PM |
MacLean Michael F |
SVP, Chief Accounting Officer |
Aug 02, 2010 |
Sale |
$56.85 |
9,542 |
542,457 |
20,494 |
Aug 03, 2010, 04:03 PM |
Clancy Paul J |
Executive VP and CFO |
Aug 01, 2010 |
Option Exercise |
$55.88 |
835 |
46,660 |
46,897 |
Aug 03, 2010, 04:01 PM |
ALEXANDER SUSAN H |
EVP, General Counsel |
Aug 01, 2010 |
Option Exercise |
$55.88 |
835 |
46,660 |
41,308 |
Aug 03, 2010, 04:00 PM |
DORSA CAROLINE |
Director |
Jul 30, 2010 |
Buy |
$54.57 |
183 |
9,986 |
8,066 |
Aug 03, 2010, 03:58 PM |
Owner |
Relationship |
Date |
Transaction |
Value($) |
Vounatsos Michel |
Chief Executive Officer |
Feb 15, 2019 |
Option Exercise |
778,916 |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 15, 2019 |
Option Exercise |
195,062 |
McKenzie Paul |
EVP Pharmaceutical Oper & Tech |
Feb 15, 2019 |
Option Exercise |
214,035 |
Ehlers Michael D |
EVP, Research and Development |
Feb 15, 2019 |
Option Exercise |
249,320 |
ALEXANDER SUSAN H |
EVP Chief Legal Officer & Sec. |
Feb 15, 2019 |
Option Exercise |
249,320 |
Vounatsos Michel |
Chief Executive Officer |
Feb 12, 2019 |
Option Exercise |
837,545 |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 12, 2019 |
Option Exercise |
804,325 |
McKenzie Paul |
EVP Pharmaceutical Oper & Tech |
Feb 12, 2019 |
Option Exercise |
293,556 |
Gregory Ginger |
EVP, Human Resources |
Feb 12, 2019 |
Option Exercise |
176,006 |
Ehlers Michael D |
EVP, Research and Development |
Feb 12, 2019 |
Option Exercise |
404,718 |
ALEXANDER SUSAN H |
EVP Chief Legal Officer & Sec. |
Feb 12, 2019 |
Option Exercise |
326,138 |
DENNER ALEXANDER J |
Director |
Jan 31, 2019 |
Buy |
8,527,393 |
DENNER ALEXANDER J |
Director |
Jan 30, 2019 |
Buy |
9,745,851 |
DENNER ALEXANDER J |
Director |
Feb 01, 2019 |
Buy |
2,299,163 |
CAPELLO JEFFREY D |
EVP & Chief Financial Officer |
Jan 02, 2019 |
Option Exercise |
126,142 |
Guindo Chirfi |
EVP Glob. Mkt Acc & Cust Innov |
Dec 01, 2018 |
Option Exercise |
136,491 |
Ehlers Michael D |
EVP, Research and Development |
Sep 26, 2018 |
Sale |
350,000 |
Gregory Ginger |
EVP, Human Resources |
Aug 01, 2018 |
Option Exercise |
56,082 |
Ehlers Michael D |
EVP, Research and Development |
Jun 01, 2018 |
Option Exercise |
319,669 |
Vounatsos Michel |
Chief Executive Officer |
May 02, 2018 |
Option Exercise |
205,598 |
DENNER ALEXANDER J |
Director |
Apr 25, 2018 |
Buy |
12,955,680 |
McKenzie Paul |
EVP Pharmaceutical Oper & Tech |
Mar 01, 2018 |
Option Exercise |
181,269 |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 27, 2018 |
Sale |
75,325 |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 23, 2018 |
Option Exercise |
60,898 |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 23, 2018 |
Sale |
266,444 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 23, 2018 |
Option Exercise |
8,198 |
ALEXANDER SUSAN H |
EVP Chief Legal Corp Svc & Sec |
Feb 23, 2018 |
Option Exercise |
111,549 |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 22, 2018 |
Option Exercise |
207,057 |
ALEXANDER SUSAN H |
EVP Chief Legal Corp Svc & Sec |
Feb 22, 2018 |
Option Exercise |
207,057 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 22, 2018 |
Option Exercise |
16,519 |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 20, 2018 |
Sale |
216,956 |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 15, 2018 |
Sale |
386,712 |
Vounatsos Michel |
Chief Executive Officer |
Feb 15, 2018 |
Option Exercise |
561,936 |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 15, 2018 |
Option Exercise |
178,430 |
Ehlers Michael D |
EVP, Research and Development |
Feb 15, 2018 |
Option Exercise |
152,384 |
ALEXANDER SUSAN H |
EVP Chief Legal Corp Svc & Sec |
Feb 15, 2018 |
Option Exercise |
152,684 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 15, 2018 |
Option Exercise |
16,765 |
McKenzie Paul |
EVP Pharmaceutical Oper & Tech |
Feb 15, 2018 |
Option Exercise |
132,326 |
Sandrock Alfred |
EVP, Chief Medical Officer |
Feb 12, 2018 |
Option Exercise |
416,685 |
PANGIA ROBERT W |
Director |
Jan 09, 2018 |
Option Exercise |
337,265 |
PANGIA ROBERT W |
Director |
Jan 09, 2018 |
Sale |
1,922,519 |
Vounatsos Michel |
Chief Executive Officer |
Dec 29, 2017 |
Buy |
250,029 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Dec 01, 2017 |
Option Exercise |
50,138 |
DENNER ALEXANDER J |
Director |
Nov 28, 2017 |
Buy |
6,322,400 |
DENNER ALEXANDER J |
Director |
Nov 29, 2017 |
Buy |
3,198,400 |
DENNER ALEXANDER J |
Director |
Aug 31, 2017 |
Option Exercise |
295,350 |
ALEXANDER SUSAN H |
EVP Chief Legal Corp Svc & Sec |
Jul 25, 2017 |
Sale |
1,442,510 |
ALEXANDER SUSAN H |
EVP Chief Legal Corp Svc & Sec |
Jul 19, 2017 |
Sale |
2,211,030 |
Posner Brian S |
Director |
Jun 09, 2017 |
Sale |
277,840 |
Ehlers Michael D |
EVP, Research and Development |
Jun 01, 2017 |
Option Exercise |
188,528 |
Vounatsos Michel |
Chief Executive Officer |
May 02, 2017 |
Option Exercise |
153,036 |
Vounatsos Michel |
Chief Executive Officer |
May 01, 2017 |
Buy |
380,433 |
DENNER ALEXANDER J |
Director |
Apr 27, 2017 |
Buy |
20,569,476 |
Clancy Paul J |
Executive VP and CFO |
Apr 25, 2017 |
Sale |
2,868,680 |
Clancy Paul J |
Executive VP and CFO |
Mar 13, 2017 |
Sale |
2,883,721 |
McKenzie Paul |
EVP Pharmaceutical Oper & Tech |
Mar 01, 2017 |
Option Exercise |
46,042 |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Mar 01, 2017 |
Sale |
282,238 |
Clancy Paul J |
Executive VP and CFO |
Feb 28, 2017 |
Option Exercise |
853,135 |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 28, 2017 |
Option Exercise |
829,217 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 28, 2017 |
Option Exercise |
670,996 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 28, 2017 |
Option Exercise |
25,386 |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Feb 28, 2017 |
Option Exercise |
211,542 |
DiPietro Kenneth |
EVP Human Resources |
Feb 28, 2017 |
Option Exercise |
684,399 |
PANGIA ROBERT W |
Director |
Jan 09, 2017 |
Option Exercise |
284,599 |
PANGIA ROBERT W |
Director |
Jan 09, 2017 |
Sale |
1,609,876 |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Dec 01, 2016 |
Option Exercise |
50,578 |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Dec 01, 2016 |
Sale |
14,233 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Dec 01, 2016 |
Option Exercise |
15,676 |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Oct 04, 2016 |
Sale |
81,728 |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Oct 01, 2016 |
Option Exercise |
591,001 |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Oct 03, 2016 |
Sale |
118,940 |
DORSA CAROLINE |
Director |
Sep 22, 2016 |
Option Exercise |
1,478,855 |
DORSA CAROLINE |
Director |
Sep 22, 2016 |
Sale |
8,656,980 |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 21, 2016 |
Sale |
43,960 |
Koppel Adam |
EVP, Strategy and Bus. Dev. |
Jun 06, 2016 |
Sale |
160,950 |
Koppel Adam |
EVP, Strategy and Bus. Dev. |
Jun 02, 2016 |
Option Exercise |
154,716 |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 03, 2016 |
Sale |
244,180 |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 01, 2016 |
Sale |
140,241 |
SCANGOS GEORGE A |
Chief Executive Officer |
May 31, 2016 |
Sale |
976,720 |
SCANGOS GEORGE A |
Chief Executive Officer |
May 25, 2016 |
Sale |
43,960 |
SCANGOS GEORGE A |
Chief Executive Officer |
May 02, 2016 |
Sale |
133,798 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2016 |
Option Exercise |
31,074 |
Koppel Adam |
EVP, Strategy and Bus. Dev. |
Apr 06, 2016 |
Sale |
28,050 |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 06, 2016 |
Sale |
43,960 |
Artavanis-Tsakonas Spyridon |
EVP, Chief Scientific Officer |
Apr 02, 2016 |
Option Exercise |
119,588 |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01, 2016 |
Sale |
126,050 |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 01, 2016 |
Sale |
127,287 |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 25, 2016 |
Sale |
47,928 |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Feb 25, 2016 |
Sale |
22,000 |
Clancy Paul J |
Executive VP and CFO |
Feb 23, 2016 |
Option Exercise |
70,704 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 23, 2016 |
Option Exercise |
5,698 |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Feb 23, 2016 |
Option Exercise |
12,432 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 23, 2016 |
Option Exercise |
77,697 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 23, 2016 |
Option Exercise |
98,934 |
Koppel Adam |
EVP, Strategy and Bus. Dev. |
Feb 23, 2016 |
Option Exercise |
25,381 |
DiPietro Kenneth |
EVP Human Resources |
Feb 23, 2016 |
Option Exercise |
77,697 |
Holtzman Steven H |
EVP Corporate Development |
Feb 23, 2016 |
Option Exercise |
70,704 |
Karaboutis Adriana |
EVP, Tech, Bus. Sol & Corp Aff |
Feb 23, 2016 |
Option Exercise |
41,956 |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 23, 2016 |
Option Exercise |
42,474 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 23, 2016 |
Option Exercise |
361,291 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 17, 2016 |
Sale |
124,750 |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 17, 2016 |
Sale |
184,948 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 12, 2016 |
Option Exercise |
2,920,904 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 12, 2016 |
Option Exercise |
383,685 |
DiPietro Kenneth |
EVP Human Resources |
Feb 12, 2016 |
Option Exercise |
338,444 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 12, 2016 |
Option Exercise |
6,428 |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 12, 2016 |
Option Exercise |
451,671 |
Holtzman Steven H |
EVP Corporate Development |
Feb 12, 2016 |
Option Exercise |
324,847 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 12, 2016 |
Option Exercise |
328,308 |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Feb 12, 2016 |
Option Exercise |
87,021 |
Clancy Paul J |
Executive VP and CFO |
Feb 12, 2016 |
Option Exercise |
420,027 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 09, 2016 |
Option Exercise |
1,326,197 |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 08, 2016 |
Option Exercise |
106,828 |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Feb 09, 2016 |
Sale |
210,052 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 08, 2016 |
Option Exercise |
206,133 |
Clancy Paul J |
Executive VP and CFO |
Feb 08, 2016 |
Option Exercise |
262,556 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 08, 2016 |
Option Exercise |
332,019 |
Holtzman Steven H |
EVP Corporate Development |
Feb 08, 2016 |
Option Exercise |
223,185 |
DiPietro Kenneth |
EVP Human Resources |
Feb 01, 2016 |
Option Exercise |
222,041 |
DiPietro Kenneth |
EVP Human Resources |
Feb 01, 2016 |
Option Exercise |
674,328 |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Dec 03, 2015 |
Option Exercise |
108,248 |
Sandrock Alfred |
EVP CMO Neuro & Neurodegenerat |
Dec 04, 2015 |
Sale |
122,157 |
Karaboutis Adriana |
EVP, Tech. and Bus. Solutions |
Dec 01, 2015 |
Option Exercise |
49,597 |
Karaboutis Adriana |
EVP, Tech. and Bus. Solutions |
Dec 02, 2015 |
Sale |
13,879 |
DENNER ALEXANDER J |
Director |
Oct 23, 2015 |
Buy |
27,676,999 |
DENNER ALEXANDER J |
Director |
Oct 22, 2015 |
Buy |
58,337,997 |
Karaboutis Adriana |
EVP, Tech. and Bus. Solutions |
Oct 05, 2015 |
Sale |
78,395 |
Karaboutis Adriana |
EVP, Tech. and Bus. Solutions |
Oct 01, 2015 |
Option Exercise |
478,642 |
Karaboutis Adriana |
EVP, Tech. and Bus. Solutions |
Oct 02, 2015 |
Sale |
118,169 |
PAPADOPOULOS STELIOS |
Director |
Jul 27, 2015 |
Buy |
1,523,880 |
PAPADOPOULOS STELIOS |
Director |
Jul 27, 2015 |
Buy |
1,524,895 |
Posner Brian S |
Director |
Jun 22, 2015 |
Sale |
195,050 |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Jun 19, 2015 |
Sale |
1,574,810 |
Posner Brian S |
Director |
Jun 15, 2015 |
Sale |
154,656 |
Koppel Adam |
SVP, Chief Strategy Officer |
Jun 02, 2015 |
Option Exercise |
330,252 |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 01, 2015 |
Sale |
543,261 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2015 |
Option Exercise |
43,643 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2015 |
Option Exercise |
134,018 |
SCANGOS GEORGE A |
Chief Executive Officer |
May 01, 2015 |
Sale |
514,182 |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Apr 02, 2015 |
Option Exercise |
189,722 |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01, 2015 |
Sale |
576,398 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Mar 27, 2015 |
Sale |
184,952 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Mar 25, 2015 |
Option Exercise |
333,571 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Mar 25, 2015 |
Sale |
5,393,211 |
Rowinsky Eric K |
Director |
Mar 20, 2015 |
Option Exercise |
697,920 |
Rowinsky Eric K |
Director |
Mar 20, 2015 |
Sale |
5,541,825 |
Rowinsky Eric K |
Director |
Mar 19, 2015 |
Option Exercise |
139,560 |
Rowinsky Eric K |
Director |
Mar 19, 2015 |
Sale |
1,017,508 |
Rowinsky Eric K |
Director |
Mar 17, 2015 |
Option Exercise |
279,180 |
Rowinsky Eric K |
Director |
Mar 17, 2015 |
Sale |
1,985,589 |
DiPietro Kenneth |
EVP Human Resources |
Mar 16, 2015 |
Sale |
333,614 |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 13, 2015 |
Sale |
221,613 |
SHERWIN STEPHEN A |
Director |
Mar 10, 2015 |
Option Exercise |
358,920 |
SHERWIN STEPHEN A |
Director |
Mar 10, 2015 |
Sale |
2,458,020 |
Rowinsky Eric K |
Director |
Mar 09, 2015 |
Option Exercise |
279,120 |
Rowinsky Eric K |
Director |
Mar 09, 2015 |
Sale |
1,946,795 |
PANGIA ROBERT W |
Director |
Mar 10, 2015 |
Option Exercise |
172,954 |
PANGIA ROBERT W |
Director |
Mar 10, 2015 |
Sale |
1,498,578 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Mar 01, 2015 |
Option Exercise |
1,157,501 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Mar 02, 2015 |
Sale |
1,299,715 |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 02, 2015 |
Sale |
338,803 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 12, 2015 |
Option Exercise |
3,137 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 19, 2015 |
Sale |
215,358 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 17, 2015 |
Sale |
321,016 |
Holtzman Steven H |
EVP Corporate Development |
Feb 17, 2015 |
Sale |
828,026 |
DiPietro Kenneth |
EVP Human Resources |
Feb 17, 2015 |
Sale |
462,263 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 17, 2015 |
Sale |
162,648 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 12, 2015 |
Option Exercise |
4,754,334 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 12, 2015 |
Option Exercise |
7,842 |
Holtzman Steven H |
EVP Corporate Development |
Feb 12, 2015 |
Option Exercise |
671,292 |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Feb 12, 2015 |
Option Exercise |
154,491 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 12, 2015 |
Option Exercise |
296,827 |
Clancy Paul J |
Executive VP and CFO |
Feb 12, 2015 |
Option Exercise |
794,415 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 12, 2015 |
Option Exercise |
690,506 |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 12, 2015 |
Option Exercise |
960,669 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 12, 2015 |
Option Exercise |
696,387 |
DiPietro Kenneth |
EVP Human Resources |
Feb 12, 2015 |
Option Exercise |
695,211 |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 12, 2015 |
Option Exercise |
665,411 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 10, 2015 |
Sale |
455,039 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 09, 2015 |
Option Exercise |
1,960,587 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 10, 2015 |
Option Exercise |
3,505,198 |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 08, 2015 |
Option Exercise |
656,868 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 08, 2015 |
Option Exercise |
328,836 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 09, 2015 |
Option Exercise |
731,053 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 09, 2015 |
Option Exercise |
270,275 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 08, 2015 |
Option Exercise |
169,242 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 09, 2015 |
Sale |
340,731 |
Holtzman Steven H |
EVP Corporate Development |
Feb 08, 2015 |
Option Exercise |
512,550 |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 09, 2015 |
Option Exercise |
341,317 |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 08, 2015 |
Option Exercise |
354,966 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 09, 2015 |
Option Exercise |
877,105 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 08, 2015 |
Option Exercise |
617,874 |
Clancy Paul J |
Executive VP and CFO |
Feb 08, 2015 |
Option Exercise |
459,486 |
Clancy Paul J |
Executive VP and CFO |
Feb 09, 2015 |
Option Exercise |
877,105 |
DiPietro Kenneth |
EVP Human Resources |
Feb 02, 2015 |
Sale |
644,234 |
DiPietro Kenneth |
EVP Human Resources |
Feb 01, 2015 |
Option Exercise |
314,052 |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 01, 2015 |
Option Exercise |
801,280 |
Holtzman Steven H |
EVP Corporate Development |
Feb 01, 2015 |
Option Exercise |
801,670 |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Dec 15, 2014 |
Sale |
686,417 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Dec 03, 2014 |
Option Exercise |
136,505 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Dec 04, 2014 |
Sale |
152,187 |
Holtzman Steven H |
EVP Corporate Development |
Dec 02, 2014 |
Sale |
587,052 |
Holtzman Steven H |
EVP Corporate Development |
Nov 11, 2014 |
Sale |
577,500 |
SCANGOS GEORGE A |
Chief Executive Officer |
Nov 03, 2014 |
Sale |
361,840 |
SCANGOS GEORGE A |
Chief Executive Officer |
Oct 01, 2014 |
Sale |
373,003 |
Holtzman Steven H |
EVP Corporate Development |
Oct 01, 2014 |
Sale |
579,198 |
SCANGOS GEORGE A |
Chief Executive Officer |
Sep 02, 2014 |
Sale |
389,690 |
SCANGOS GEORGE A |
Chief Executive Officer |
Aug 01, 2014 |
Sale |
375,545 |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 16, 2014 |
Sale |
3,847,149 |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 15, 2014 |
Option Exercise |
3,139,344 |
Posner Brian S |
Director |
Jun 20, 2014 |
Sale |
190,575 |
Posner Brian S |
Director |
Jun 13, 2014 |
Sale |
217,350 |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 02, 2014 |
Sale |
154,362 |
Holtzman Steven H |
EVP Corporate Development |
May 19, 2014 |
Sale |
353,052 |
SCANGOS GEORGE A |
Chief Executive Officer |
May 01, 2014 |
Sale |
606,241 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2014 |
Option Exercise |
32,403 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2014 |
Option Exercise |
99,502 |
Holtzman Steven H |
EVP Corporate Development |
Apr 17, 2014 |
Sale |
355,311 |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Apr 02, 2014 |
Option Exercise |
134,100 |
PANGIA ROBERT W |
Director |
Apr 01, 2014 |
Option Exercise |
297,187 |
PANGIA ROBERT W |
Director |
Apr 01, 2014 |
Sale |
1,927,625 |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01, 2014 |
Sale |
654,776 |
Posner Brian S |
Director |
Mar 31, 2014 |
Sale |
890,275 |
DORSA CAROLINE |
Director |
Mar 20, 2014 |
Option Exercise |
536,400 |
DORSA CAROLINE |
Director |
Mar 20, 2014 |
Sale |
3,488,812 |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Mar 19, 2014 |
Sale |
1,234,776 |
Holtzman Steven H |
EVP Corporate Development |
Mar 17, 2014 |
Sale |
408,827 |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 10, 2014 |
Sale |
8,719,378 |
LEAMING NANCY |
Director |
Mar 10, 2014 |
Sale |
655,300 |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Mar 11, 2014 |
Sale |
2,838,766 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Mar 04, 2014 |
Sale |
1,086,321 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Mar 03, 2014 |
Option Exercise |
963,784 |
SCANGOS GEORGE A |
Chief Executive Officer |
Mar 03, 2014 |
Sale |
987,894 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 26, 2014 |
Sale |
358,594 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 23, 2014 |
Option Exercise |
326,283 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 23, 2014 |
Option Exercise |
426,251 |
Clancy Paul J |
Executive VP and CFO |
Feb 23, 2014 |
Option Exercise |
700,468 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 23, 2014 |
Option Exercise |
625,839 |
Holtzman Steven H |
EVP Corporate Development |
Feb 18, 2014 |
Sale |
400,694 |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 12, 2014 |
Option Exercise |
544,322 |
Clancy Paul J |
Executive VP and CFO |
Feb 12, 2014 |
Option Exercise |
427,705 |
Artavanis-Tsakonas Spyridon |
SVP, Chief Scientific Officer |
Feb 12, 2014 |
Option Exercise |
77,207 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 12, 2014 |
Option Exercise |
326,270 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 12, 2014 |
Option Exercise |
118,556 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 13, 2014 |
Sale |
134,478 |
Holtzman Steven H |
EVP Corporate Development |
Feb 12, 2014 |
Option Exercise |
326,270 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
Feb 12, 2014 |
Option Exercise |
2,584 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 12, 2014 |
Option Exercise |
1,399,732 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 13, 2014 |
Sale |
153,970 |
DiPietro Kenneth |
EVP Human Resources |
Feb 12, 2014 |
Option Exercise |
308,826 |
DiPietro Kenneth |
EVP Human Resources |
Feb 13, 2014 |
Sale |
408,685 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 12, 2014 |
Option Exercise |
342,099 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 11, 2014 |
Sale |
655,336 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 11, 2014 |
Sale |
771,945 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 10, 2014 |
Option Exercise |
2,801,995 |
SCANGOS GEORGE A |
Chief Executive Officer |
Feb 09, 2014 |
Option Exercise |
1,530,369 |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 09, 2014 |
Option Exercise |
271,680 |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 08, 2014 |
Option Exercise |
392,216 |
Clancy Paul J |
Executive VP and CFO |
Feb 09, 2014 |
Option Exercise |
697,974 |
Clancy Paul J |
Executive VP and CFO |
Feb 08, 2014 |
Option Exercise |
330,370 |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 08, 2014 |
Option Exercise |
516,223 |
Holtzman Steven H |
EVP Corporate Development |
Feb 08, 2014 |
Option Exercise |
402,629 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 09, 2014 |
Option Exercise |
187,431 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Feb 08, 2014 |
Option Exercise |
133,158 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 08, 2014 |
Option Exercise |
258,427 |
ALEXANDER SUSAN H |
EVP, Chief Legal Officer |
Feb 09, 2014 |
Option Exercise |
550,933 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 09, 2014 |
Option Exercise |
697,974 |
Cox John |
EVP Pharmaceutical Oper & Tech |
Feb 08, 2014 |
Option Exercise |
454,693 |
DiPietro Kenneth |
EVP Human Resources |
Feb 04, 2014 |
Sale |
494,862 |
DiPietro Kenneth |
EVP Human Resources |
Feb 01, 2014 |
Option Exercise |
252,613 |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Feb 01, 2014 |
Option Exercise |
615,588 |
Kingsley Stuart A |
EVP, Global Comm. Operations |
Feb 01, 2014 |
Option Exercise |
531,801 |
Holtzman Steven H |
EVP Corporate Development |
Feb 01, 2014 |
Option Exercise |
616,213 |
Rowinsky Eric K |
Director |
Jan 21, 2014 |
Sale |
626,382 |
SCHENK LYNN |
Director |
Jan 15, 2014 |
Sale |
297,480 |
YOUNG WILLIAM |
Director |
Jan 08, 2014 |
Sale |
4,276,590 |
PANGIA ROBERT W |
Director |
Jan 06, 2014 |
Option Exercise |
297,187 |
PANGIA ROBERT W |
Director |
Jan 06, 2014 |
Sale |
1,737,687 |
SHERWIN STEPHEN A |
Director |
Jan 02, 2014 |
Option Exercise |
329,010 |
SHERWIN STEPHEN A |
Director |
Jan 02, 2014 |
Sale |
1,536,059 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Dec 03, 2013 |
Option Exercise |
113,377 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Dec 04, 2013 |
Sale |
125,510 |
SCHENK LYNN |
Director |
Dec 02, 2013 |
Sale |
291,710 |
Pawlicki Raymond |
SVP, Chief Information Officer |
Nov 22, 2013 |
Option Exercise |
199,800 |
Pawlicki Raymond |
SVP, Chief Information Officer |
Nov 22, 2013 |
Sale |
1,152,000 |
SCHENK LYNN |
Director |
Nov 01, 2013 |
Sale |
245,000 |
SCANGOS GEORGE A |
Chief Executive Officer |
Nov 01, 2013 |
Sale |
549,831 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Oct 22, 2013 |
Option Exercise |
910,217 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Oct 22, 2013 |
Sale |
3,759,123 |
SCHENK LYNN |
Director |
Oct 01, 2013 |
Sale |
242,850 |
SCANGOS GEORGE A |
Chief Executive Officer |
Oct 01, 2013 |
Sale |
543,741 |
DiPietro Kenneth |
EVP Human Resources |
Sep 30, 2013 |
Sale |
348,480 |
Clancy Paul J |
Executive VP and CFO |
Sep 18, 2013 |
Option Exercise |
1,329,875 |
Clancy Paul J |
Executive VP and CFO |
Sep 18, 2013 |
Sale |
6,562,325 |
Clancy Paul J |
Executive VP and CFO |
Sep 16, 2013 |
Option Exercise |
5,556,895 |
Clancy Paul J |
Executive VP and CFO |
Sep 16, 2013 |
Sale |
23,596,311 |
Holtzman Steven H |
EVP Corporate Development |
Sep 17, 2013 |
Sale |
836,669 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Sep 16, 2013 |
Option Exercise |
487,563 |
Sandrock Alfred |
Grp SVP, Chief Medical Officer |
Sep 16, 2013 |
Sale |
2,357,821 |
Pawlicki Raymond |
SVP, Chief Information Officer |
Sep 16, 2013 |
Option Exercise |
198,360 |
Pawlicki Raymond |
SVP, Chief Information Officer |
Sep 16, 2013 |
Sale |
952,120 |
SCHENK LYNN |
Director |
Sep 11, 2013 |
Sale |
211,726 |
SCANGOS GEORGE A |
Chief Executive Officer |
Sep 03, 2013 |
Sale |
480,042 |
WILLIAMS DOUGLAS E |
EVP Research & Development |
Aug 26, 2013 |
Sale |
923,168 |
SCANGOS GEORGE A |
Chief Executive Officer |
Aug 01, 2013 |
Sale |
489,938 |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 16, 2013 |
Sale |
501,402 |
SCANGOS GEORGE A |
Chief Executive Officer |
Jul 15, 2013 |
Option Exercise |
4,489,068 |
DENNER ALEXANDER J |
Director |
Jun 14, 2013 |
Sale |
614,800 |
PAPADOPOULOS STELIOS |
Director |
Jun 11, 2013 |
Sale |
443,632 |
Posner Brian S |
Director |
Jun 11, 2013 |
Sale |
443,632 |
SCHENK LYNN |
Director |
Jun 10, 2013 |
Sale |
451,633 |
SCANGOS GEORGE A |
Chief Executive Officer |
Jun 03, 2013 |
Sale |
374,188 |
SHERWIN STEPHEN A |
Director |
Jun 03, 2013 |
Option Exercise |
767,191 |
SHERWIN STEPHEN A |
Director |
Jun 03, 2013 |
Sale |
2,991,605 |
Mulligan Richard |
Director |
May 29, 2013 |
Option Exercise |
160,290 |
DENNER ALEXANDER J |
Director |
May 29, 2013 |
Option Exercise |
160,290 |
Mulligan Richard |
Director |
May 28, 2013 |
Option Exercise |
2,029,004 |
Mulligan Richard |
Director |
May 28, 2013 |
Sale |
9,140,100 |
DENNER ALEXANDER J |
Director |
May 28, 2013 |
Option Exercise |
2,029,004 |
DENNER ALEXANDER J |
Director |
May 28, 2013 |
Sale |
9,135,697 |
PANGIA ROBERT W |
Director |
May 28, 2013 |
Sale |
1,399,657 |
Pawlicki Raymond |
SVP, Chief Information Officer |
May 03, 2013 |
Option Exercise |
189,524 |
Cox John |
EVP Pharmaceutical Oper & Tech |
May 03, 2013 |
Option Exercise |
189,524 |
COVINO GREGORY F |
VP, Chief Accounting Officer |
May 01, 2013 |
Option Exercise |
24,434 |
SCANGOS GEORGE A |
Chief Executive Officer |
May 01, 2013 |
Sale |
344,193 |
Clancy Paul J |
Executive VP and CFO |
Apr 30, 2013 |
Sale |
3,255,090 |
Clancy Paul J |
Executive VP and CFO |
Apr 29, 2013 |
Sale |
2,004,414 |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01, 2013 |
Sale |
309,469 |
SCANGOS GEORGE A |
Chief Executive Officer |
Apr 01, 2013 |
Sale |
309,469 |
Mulligan Richard |
Director |
Mar 22, 2013 |
Sale |
|